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Abstract
Cell surface receptors allow the cell to sense and respond to external signals. Receptor malfunc-
tions are associated with many diseases. The diffusional behavior of receptors is of particular
interest to understand how the cell modulates receptor function in the complex, heterogenous
plasma membrane. Unlike traditional ensemble methods, single-molecule techniques give
access to events taking place at the nanometer scale and millisecond time regime, provid-
ing unprecedented means to correlate biological functions of the cell membrane with the
spatio-temporal organization of its individual components.
In this work, advanced ﬂuorescence microscopy techniques were used to track the motion of
individual receptors in the plasma membrane of living cells to elucidate principles regulating
their function. Two very different neurotransmitter receptors were investigated: the G protein
coupled neurokinin-1 receptor (NK1R), and the ionotropic serotonin type 3 receptor (5-HT3R).
The ﬁrst important step towards tracking single receptor molecules is the speciﬁc labeling of a
small fraction of these receptors with a photostable ﬂuorescent probe. The choice of a suitable
labeling strategy is of paramount importance, as it will largely determine the success of the
experiment. Single-molecule tracking requires extremely speciﬁc, long-lasting, stoichiometric
and bright ﬂuorescent labels that do not interfere with the function and diffusion of the
receptor.
For the NK1R, a two-step labeling strategy based on the strong biotin-streptavidin interac-
tion yielded the best labeling speciﬁcity. Enzymatic biotinylation of the receptor followed
by binding streptavidin-coated quantum dot (QDot) enabled a straightforward and precise
adjustment of the label density to a few QDots per cell. The combination of high bright-
ness and photostability of semi-conductor QDots allowed us to record receptor trajectories
with high spatial resolution over long time periods. The investigation of thousands of single
NK1R trajectories revealed a very heterogeneous mobility pattern with two major, broadly
distributed receptor populations, one showing high mobility and low lateral restriction, the
other low mobility and high restriction. We found that 40% of the receptors in the basal state
are already conﬁned in membrane domains. After agonist stimulation, an additional 30% of
receptors became further conﬁned. Using inhibitors of clathrin-mediated endocytosis, we
showed that the fraction of conﬁned receptors at the basal state depends on the quantity of
membrane-associated clathrin and is correlated to a signiﬁcant decrease of the receptors’
canonical pathway activity. These ﬁndings add further insights to the plasticity of receptor
signaling.
There is a risk that one streptavidin-coated QDot could bind several biotinylated receptors and
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thereby alter the receptor’s mobility. The generation of monovalent StrepTactin-conjugated
QDots allowed us to exclude any cross-linking artifacts in our previous measurements of NK1R
diffusion.
In the case of the 5-HT3R, the diffusion of individual receptors was followed using a ﬂuorescent
nanobody (VHH15-CF640R). This novel high-afﬁnity label which is small, monovalent and
highly photostable enabled us to track native 5-HT3Rs over long time regimes, revealing a
surprising and intriguing diffusional behavior of some receptors.
Key words: Fluorescence microscopy, single-molecule tracking, plasma membrane, protein
labeling, membrane protein diffusion, G protein-coupled receptors, neurokinin-1 receptor,
ligand-gated ion channels, 5-HT3 receptor, quantum dots, monovalent StrepTactin, single-
domain antibodies.
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Résumé
Les récepteurs présents à la surface des cellules permettent à ces dernières de percevoir des
signaux extérieurs et d’y répondre. Leur dysfonctionnement est à l’origine de nombreuses
maladies. L’étude de la diffusion des récepteurs est d’un intérêt particulier pour comprendre
comment la cellule module leur fonction au niveau de la membrane plasmique. L’hétérogé-
néité de cette dernière rend l’utilisation de techniques permettant la détection de molécules
individuelles particulièrement adaptée. En effet, contrairement aux mesures d’ensemble, ces
techniques permettent d’accéder à des événements prenant place à l’échelle du nanomètre
et de la milliseconde, et offrent ainsi la possibilité de corréler les fonctions biologiques de la
membrane avec l’organisation spatio-temporelle de ses composants individuels.
Dans ce travail, des techniques avancées de microscopie de ﬂuorescence ont été utilisées pour
suivre le mouvement de récepteurs individuels dans la membrane de cellules vivantes aﬁn
d’élucider les principes régulant leur fonction. Deux neurorécepteurs très différents ont été
investigués : le récepteur de la neurokinine 1 (NK1) couplé aux protéines G et le récepteur
ionotropique de la sérotonine (5-HT3).
La première étape pour pouvoir suivre des molécules uniques est le marquage spéciﬁque
d’une petite fraction des récepteurs avec une sonde ﬂuorescente. Pour que l’expérience soit
un succès, la sonde en question doit se lier de manière spéciﬁque, stœchiométrique et durable
au récepteur, être brillante et photostable, et ne pas interférer avec la fonction ou la diffusion
du récepteur.
Pour le récepteur NK1, une stratégie de marquage en deux étapes s’est avérée supérieure en
terme de spéciﬁcité. La biotinylation enzymatique du récepteur, suivie par la liaison de boîtes
quantiques (QDots) liées à la streptavidine a permis d’ajuster aisément la densité du marquage
à quelques QDots par cellule. Grâce à l’exceptionnelle brillance et photstabilité des QDots,
nous avons été capable de reconstituer les mouvements du récepteur avec une très grande
précision spatiale sur de longues périodes. L’investigation de milliers de trajectoires a révélé
une diffusion très hétérogène avec deux populations majeures de récepteurs, l’une exhibant
une grande mobilité et une faible restriction latérale, l’autre une faible mobilité et une grande
restriction latérale. Nous avons découvert que 40% des récepteurs étaient déjà conﬁnés dans
des domaines à l’état basal. Après stimulation avec un agoniste, 30% supplémentaires sont
devenus conﬁnés. En utilisant des inhibiteurs de l’endocytose dépendante de la clathrine,
nous avons montré que la fraction de récepteurs conﬁnés à l’état basal dépend de la quantité
de clathrine associée à la membrane et est corrélée avec une inhibition de l’activé de la
voie de signalisation canonique. Ces résultats offrent un nouvel aperçu de la plasticité de la
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signalisation du récepteur NK1.
Il y a un risque qu’un QDot lié à la streptavidine puisse se lier à plusieurs récepteurs biotinylés
et, de ce fait, en altérer la mobilité. La génération de QDots liés à une StrepTactin monovalente
nous a permis d’exclure tout artefact de ce type dans nos précédentes mesures.
Dans le cas du récepteur 5-HT3, la diffusion de récepteurs individuels a été investiguée en
utilisant un nanobody ﬂuorescent (VHH15-CF640R). Ce nouveau marqueur qui est à la fois
petit, monovalent et photostable, nous a permis de suivre des récepteurs natifs pendant de
longues périodes et ainsi de révéler le comportement surprenant et intriguant de certains
d’entre eux.
Mots clefs : Microscopie de ﬂuorescence, suivi de molécules uniques, membrane plasmique,
marquage de protéines, diffusion de protéines membranaires, récepteurs couplés aux pro-
téines G, récepteur neurokinine 1, canaux ioniques ligand-dépendants, récepteur 5-HT3,
boîtes quantiques, StrepTactin monovalente, anticorps à domaine unique.
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Aim and scope of this thesis
The central goal of this PhDproject was the study of the lateralmobility ofmembrane receptors
at the single-molecule level in living cells. The lateral diffusion of membrane proteins is a
surprisingly complex phenomenon which plays a central role in the regulation of many cellular
signaling processes. Revealing how the plasma membrane laterally organizes and controls the
mobility of its constituents at the nanoscopic level is essential to understand central functional
processes of a cell. In order to do so, methods enabling detection of single-molecules with
high spatial and temporal resolution are needed. In this context, single-molecule tracking
(SPT) of receptors labeled with quantum dots (QDots) as ﬂuorescent probes is particularly
well suited and is therefore at the center of this PhD project.
The thesis starts with a general introduction. It provides an overview of the scientiﬁc topics
treated in the following chapters, including the biological background and the experimental
methods concerned.
Chapter 1 (p. 31) presents different labeling strategies that have been assessed in order to
attach QDots to the neurokinin-1 (NK1) receptor which has been chosen as a prototypical
representative of a G protein-coupled receptor. The objective was to establish a protocol
providing maximum labeling speciﬁcity and stability for studying the diffusion of single
receptors in the plasma membrane of living cells.
In chapter 2 (p. 39), the labeling strategy established in the previous chapter is applied to track
trajectories of individual NK1 receptors over long time periods with high lateral precision in
order to solve important biological questions, such as what are the underlying causes of the
restricted mobility of the receptor, and how does the receptor’s spatio-temporal distribution
inﬂuence the transmembrane signaling network. The results of this study have been published
in an article entitled “Single-molecule imaging deciphers the relation between mobility and
signaling of a prototypical G protein-coupled receptor in living cells” in the Journal of Biological
Chemistry.
Chapter 3 (p. 63) presents a new approach based on a engineered StrepTactin protein to label
membrane receptors without risk of cross-linking. The aim was to produce a StrepTactin
tetramer (a geneticallymodiﬁed formof streptavidin)with only one functional binding site that
retained the intrinsic afﬁnity of the wild-type protein towards biotin and strep-tagged proteins.
1
Aim and Scope of this Thesis
The ﬁnal purpose was to use this monovalent StrepTactin to speciﬁcally label biotinylated or
Strep-tagged receptors with QDots for SPT experiments.
Chapter 4 (p. 79) focuses on the 5-HT3 receptor, an important member of the superfamily of
Cys-loop ligand-gated ion channels. Here the goal was to use the nanobody VHH15 (recently
developed to improve crystallization for structure determination of the 5-HT3 receptor) to
label and track individual 5-HT3 receptors in primary neurons endogenously expressing the
receptor.
2
General introduction
The plasma membrane
The cellular plasma membrane is a 5 nm-thin ﬂexible layer with fascinating and intriguing
functions separating the interior of the cell from the outside environment and thereby deﬁn-
ing the cell’s dimension. The plasma membrane is far more than a simple barrier; it is a
very complex and highly dynamic structure, composed of many different lipid and protein
species, involved in fundamental cellular processes such as the transmission of matter and
information between the outside and the inside of the cell. Tools for exploring the structural
and dynamic organization of the plasma membrane on relevant spatial and temporal scales
are still emerging, and our comprehension of this extraordinary biological entity at the basis
of our existence is far from complete.
Lipids and proteins
The plasma membrane is primarily composed of amphiphilic lipids which are made up of
polar head groups and hydrophobic tails (acyl chains). In an aqueous environment, lipids
spontaneously self-assemble into membrane structures such as bilayers, vesicles or micelles
as illustrated in Figure 1. This process, primarily driven by entropy, is commonly referred to as
the hydrophobic effect and causes the lipid acyl chains and head groups to arrange in such a
manner that the hydrophobic surface area exposed to the aqueous phase is minimized.
In the cell membrane, the lipids form a bilayer in which all the acyl chains point toward
its center, while the polar head groups are oriented toward the aqueous phase. The lipid
membrane is thus only two lipid molecules thick, i.e. about 5 nm. Despite being extremely
thin, the plasma membrane functions as an efﬁcient barrier. In absence of transmembrane
proteins, a lipid bilayer is virtually impermeable to ions and to most water-soluble molecules,
such as glucose or amino acids. This property is essential for fundamental cellular processes
such as maintenance of ionic concentration gradients which are of critical importance for
generation and propagation of action potentials that underlie the functioning of the nervous
system [1].
Eukaryotic cell membranes are composed of a large variety of different lipid species [2],
3
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including glycerophospholipids, sphingolipids, and cholesterol. Lipids have multiple func-
tions; they are of particular importance for energy storage, signaling and regulating membrane
ﬂuidity.
~ 5 nm
MicelleVesicleLipid
Polar head
Lipid bilayer
Hydrophobic tails
Figure 1: Lipid structures. Lipids are amphiphilic molecules with a polar head group and
a non-polar tail (acyl chains). They can self-assemble into different structures such as a
spherical vesicle, a micelle or a planar lipid bilayer.
The plasma membrane also contains proteins. Integral membrane proteins form transmem-
brane domains with amino acid residues with hydrophobic side chains that interact with
the hydrophobic inner region of the bilayer. They represent about 1/3 of the total human
proteome [3]. The protein content in the plasma membrane varies between 20-80% between
different cell types according to the cells’ function [4]. An important part of these membrane
proteins are receptors that transmit extracellular signals across the membrane. The different
receptor types in a mammalian plasma membrane are described below (p.8).
Membrane organization and lateral diffusion
In 1935, Danielli and Davson postulated that a cell membrane is composed of a lipid bilayer
covered on both sides by globular proteins [5]. This model persisted until Singer and Nicholson
proposed the ﬂuid-mosaic model [6], which describes the membrane as a two-dimensional
ﬂuid with phospholipids and embedded proteins moving freely laterally. The term mosaic
refers to the heterogeneous plasma membrane composition both in time and space. This
model is still considered as correct to describe the general structural features of biological
membranes although it has been largely reﬁned. The development of high resolution mi-
croscopy techniques in the past 20 years led to a better understanding of plasma membrane
organization on a nanometer scale [7].
According to the ﬂuid-mosaic model, membrane proteins are randomly distributed and diffuse
freely and uniformly in a two-dimensional plane. Saffman and Delbrück derived a theore-
tical relation for the lateral diffusion of molecules in a Singer-Nicholson membrane, where
4
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D ∝ ln(1/r ), with r the radius of the molecule and D, the diffusion coefﬁcient within the
membrane plane [8]. However, experimental evidences have accumulated suggesting a locally
restricted mobility of proteins in the plasma membrane of living cells. It has been shown that
the diffusion of membrane proteins and lipids is slower by a factor 5-50 in plasma membranes
than in artiﬁcial reconstituted membranes or liposomes [9, 10]. Such a reduction cannot be
explained by lipid composition, e.g. addition of cholesterol [11]. This suggests signiﬁcant
barriers and obstacles for protein diffusion [9, 12, 13]. Furthermore, several research groups
have shown, especially using single molecule tracking (SMT), that "big" molecular complexes
(e.g. clusters of membrane proteins) diffuse much slower than predicted by the Saffman and
Delbrück equation, even leading to total immobilization of the proteins [10, 14, 15, 16, 17].
Elucidating the mechanisms for such slowing effects is of utmost importance for understand-
ing the signal transduction mechanisms taking place at, in and across the cell membrane
[18]. Present models assume that membranes are composed of dynamic spatially segregated
domains [7]. Two prevailing models of small-scale organization of the cell membrane allow to
explain the two conﬂicts with the Singer-Nicholson model described above: the cytoskeleton
fence [19] and lipid micro-domains [13], also known as lipid rafts [20]. These structures may
inﬂuence the mobility of membrane-associated and -integrated molecules.
Cytoskeleton compartments
The shape and internal organization of a cell is maintained by the cytoskeleton, an intracel-
lular scaffold, extensively and intimately interacting with the plasma membrane [21]. The
cytoskeleton of eukaryotic cells is made up of three major kinds of ﬁlamentous proteins: actin
microﬁlaments, microtubules which are polymeric tubulin, and intermediate ﬁlaments which
are composed of different proteins. The cytoskeleton is a highly dynamic network capable
of changing its dimension and shape very rapidly according to the cell’s requirements. Its
dynamic re-organization is essential for controlling cell polarity, cellular division or synapse
formation [21]. A variety of cytoskeletal drugs that stabilize or destabilize actin ﬁlaments
or microtubules have been discovered, and are extensively used to study the cytoskeletal
inﬂuence on cellular functions [22].
The cytoskeleton plays an important role on the organization of the components of the plasma
membrane [23]. The hypothesis that the actin cytoskeleton forms a boundary network on the
membrane [24], which may be responsible for temporary conﬁnement of membrane proteins
and lipids has been proposed by Akihiro Kusumi [9, 10, 24, 25, 26, 27]. Kusumi’s group was the
ﬁrst to highlight a possible correlation between the cytoskeleton and the mobility of mem-
brane particles by investigating the mobility of band 3 protein (an erythrocyte anion channel)
in erythrocyte ghost membranes using ﬂuorescence recovery after photobleaching (FRAP)
microscopy. They observed that the fraction of immobile band 3 protein in the membrane de-
creased upon diminution of spectrin polymers (a cytoskeleton-associated protein) [28]. Later
they performed many SMT experiments on diverse membrane-associated molecules demon-
strating that membrane proteins can be spatially conﬁned within 30-700 nm compartments
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and undergo non-Brownian diffusion in the plasma membrane, for example short-term con-
ﬁned diffusion in a compartment and long-term hop diffusion over the compartments [29]
[30] [31]. This led to the proposal of the membrane-skeleton fence model (Figure 2A). An
important consequence of this model is that the rate of diffusion cannot be described by a
single diffusion coefﬁcient [32].
Figure 2: Schematic illustration of Kusumi’s anchored-picket-fence model. The plasma
membrane is compartmentalized by (A) the actin-based membrane-skeleton (MSK) "fences"
and (B) the transmembrane proteins anchored to and aligned along the MSK ("pickets"). In the
short term, barriers formedby the corticalMSK (i.e. the portion of the cytoskeleton that lies just
beneath the plasma membrane) and the associated anchored proteins compartmentalized the
diffusion of transmembrane proteins and lipids. However, on longer timescales, the molecule
may escape and move to a neighboring compartment (hop diffusion) when a space allowing
the passage of the molecule is formed as a consequence of the thermal ﬂuctuations. Taken
from [27].
An unexpected observation arose from the tracking of the lipid DOPE (1,2-dioleoyl-sn-glycero-
3-phosphoethanolamine): in the outer leaﬂet of the plasma membrane this lipid also under-
goes hop-diffusion, despite the fact that it does not span the membrane and is therefore not in
direct contact with the cytoskeleton [11]. To explain this observation, the authors proposed the
anchored membrane-protein picket model (Figure 2B) in which the transmembrane proteins
anchored and aligned along the actin-based membrane-skeleton may act as rows of pickets,
temporally conﬁning the phospholipids [11]. According to this model, the barrier effect against
the free diffusion of lipids and proteins may be due to steric hinderance and circumferential
slowing (hydrodynamic-like friction effect near the anchored membrane proteins which slows
down the diffusion) [11].
The only cloud on the horizon for these models based on hop-diffusion is that experimental
validation from other research groups and with complementary methods is relatively limited.
Nevertheless, the picket-fence model remains very attractive, as it explains convincingly why
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the diffusion of both lipids and proteins is reduced by an order of magnitude compared to
synthetic membranes.
Lipid raft domains
The raft hypothesis postulates that the membrane is able to laterally segregate its constituents
(dynamic liquid-liquid immiscibility of regions enriched in cholesterol and sphingolipids [33])
creating nanometer-sized domains which over time can change size, composition and lateral
position. These membrane domains are supposed to act as platforms for membrane signaling
and trafﬁcking [20]. Although thousands of papers on lipid rafts have been published, there
is still controversy about their existence in the cellular plasma membrane, their size, and
function [34].
Originally, lipid rafts were deﬁned as detergent resistant membrane (DRM) fractions, insol-
uble in non-ionic detergents such as Triton X-100 at low temperatures (e.g., 4°C). If we add
such a detergent to the cells, the ﬂuid membrane will dissolve while the DRM fractions may
remain intact and could be isolated by sucrose gradient ultracentrifugation. This extraction
method has received much criticism, because it has been shown that it induces a substantial
reorganization of the plasma membrane leading to variable, and sometimes inconsistent
results.
In model membranes, cholesterol and sphingomyelin, the two major "raft molecules", often
form large micrometer-sized domains. However, despite the variety of experimental tech-
niques available [35], such domains have never been observed in live cells.
This has led to the postulations that lipid rafts are small, smaller than the resolving power
of a conventional optical microscope (i.e. ca. 200 nm) and that they are highly dynamic
and short-lived (milliseconds or less) structures. This complicates considerably the question
and requires the use of cutting-edge super-resolution microscopy techniques, such as STED-
FCS (Stimulated Emission Depletion-Fluorescence Correlation Spectroscopy) microscopy
[36]. But to date, rafts have still not been directly observed in a living cell. On the contrary,
recent papers would seem rather to indicate that nanodomains based on lipid-mediated
phase separation do not exist [37] [38]. Sevcski and coworkers rearranged a ﬂuorescent
glycosylphosphatidylinositol(GPI )-anchored protein (a typical raft-associated molecule), in
the plasma membrane of living cells using protein micropatterning and then measured the
effect on the local membrane environment using super-resolution single-molecule tracking.
Their results showed that "GPI-anchored proteins do not inﬂuence their membrane environ-
ment over distances beyond their actual physical size by stabilizing ordered membrane domains"
[38]. By demonstrating that GPI-anchored proteins do not reside in ordered domain, the raft
hypothesis might be questioned. If phase partitioning could no longer be considered as
a cornerstone of protein organization in the plasma membrane, then the role of the actin
meshwork in close proximity to the plasma membrane would be further strengthened in this
context.
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Cell-surface receptors
The ability of organisms, or individual cells to sense and react to different physical (e.g. light,
temperature, pressure) or chemical (e.g. odorant molecules, hormones, neurotransmitters,
peptides, lipids) stimuli is crucial for their survival. In most cases, these various external
signals are sensed by cell-surface receptors which transduce that information across the
plasma membrane and alter intracellular molecules leading to a cellular response. According
to the transduction mechanism used, three major classes of cell-surface receptors can be
deﬁned [39]:
• G protein-coupled receptors (GPCRs) (Figure 3A) regulate the activity of separate effector
proteins bound to the plasma membrane which can be either an enzyme or an ion channel.
The interaction between the receptor and the effector is generally mediated by a trimeric
guanosine triphosphate (GTP)-binding protein (G protein).
• Ion channel-linked receptors (ICLRs) (Figure 3B) are involved in particular in rapid synaptic
signaling between electrical excitable cells. Neurotransmitters released from the presynaptic
cell control the opening of the channel which changes the ionic permeability of the postsy-
naptic membrane, triggering an action potential.
• Activation of enzyme-linked receptors (Figure 3C) causes enzymatic activity in their in-
tracellular domain. They can function directly as enzymes or be associated with enzymes
that they activate; the great majority of these receptors are protein kinases, or associate with
protein kinases. Receptor tyrosine kinases (RTKs) are particularly important type of enzyme-
linked receptors which recognize many polypeptide growth factors, cytokines, and hormones
(e.g. insulin) and play important roles in growth, proliferation, differentiation, making them
essential for the cell survival [39].
There are some cell-surface receptors that do not ﬁt into any of the above classes, in particular
receptors that activate signaling pathways that depend on proteolysis such as the notch
receptors [40, 41].
Figure 3: Cell-surface receptors superfamilies. (A) G protein-linked receptors, (B) ion
channel-linked receptors, and (C) enzyme-linked receptors.
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In the present thesis, a GPCR, the neurokinin-1 receptor (NK1R), and a ICLR, the serotonin
5-HT3 receptor (5-HT3R) will be in the spotlight. A general description of these two cell-surface
receptors is given below.
G protein-coupled receptors
GPCRs represent the largest family of membrane proteins in the human genome, with almost
1000 members [42]. Members of this family exhibits a common structural motif consisting
of seven membrane-spanning regions — explaining why they are sometimes called seven-
transmembrane domain (7TM) receptors (for a review of the structural aspects of GPCR
signaling, see [43]). These receptors can be activated by a tremendous variety of stimuli such
as neurotransmitters, hormones, pheromones, growth factors, drugs, odors, and even photons
[44]. GPCRs are involved in an incredible array of functions in the human body and play a role
in many diseases. In fact, they represent the richest source of targets for the pharmaceutical
industry [45]. We estimate that between one-third and one half of all marketed drugs act by
binding GPCRs [46]. The 2012 Nobel Prize in Chemistry was awarded to Brian Kobilka and
Robert Lefkowitz for their work crucial for understanding how GPCRs function [47].
GPCR activation and canonical signal transduction pathways
In the classical view of GPCR signalling, when a ligand binds to a GPCR, the latter undergoes a
conformational change that activates heterotrimeric G proteins present inside the cell. These
signaling proteins are composed of three different subunits (α, β and γ) and can bind guanyl
nucleotides. The α and γ subunits are usually anchored to the membrane via aliphatic chains
[48]. In the G protein’s inactive state, a GDP (guanosine diphosphate) molecule is bound to the
α subunit (referred to as Gα) which is a P-loop NTPase, where the motif Gly-X-X-X-X-Gly-Lys
interacts with phosphoryl groups on the bound nucleotide. After activation, Gα releases GDP
and binds GTP. This leads to the dissociation of Gα from the βγ-associated subunits (Gβγ).
It is important to note that a single activated-receptor can stimulate nucleotide exchange in
many G-protein heterotrimers resulting in an ampliﬁed response [49]. Both Gα-GTP and Gβγ
can then activate different intracellular second messenger signaling cascades and effector
proteins.
There are three main transduction pathways involved in GPCR signaling depending on the α
subunit type (Gαs , Gαi/o , Gαq/11, Gα12/13) [50]:
cAMP signal pathway The GTP-bound form of Gαs activates, and of Gαi/o inhibits adenylate
cyclase (AC), an enzyme that catalyzes formation of cyclic adenosine monophosphate (cAMP)
from ATP (adenosine triphosphate). In the ﬁrst case, each activated AC can catalyze the forma-
tion of many cAMP molecule (second level of ampliﬁcation). The resulting cAMP concentra-
tion increase regulates the activity of several ion channels as well as protein kinase A (PKA),
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thereby inﬂuencing diverse cellular processes (Figure 4A).
Phosphatidylinositol signal pathway The phosphatidylinositol pathway is mediated by
Gαq/11 which activates phospholipase C (PLC). The latter catalyzes the cleavage of a mem-
brane lipid (phosphatidylinositol 4,5-biphosphate, PIP2) to produce two secondary messen-
gers: inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG). Soluble IP3 diffuses away
from the membrane and binds to IP3 sensitive calcium channels found in the endoplasmic
reticulum (ER) membrane leading to Ca2+ release (Figure 4B). Plasma membrane embedded
DAG activates protein kinase C (PKC), a kinase targeting serine and threonine residues. DAG
binding domain of PKC requires calcium ions to bind DAG. Thus, DAG and IP3 work in tandem:
IP3 increases the Ca2+ concentration, which in turn, facilitates PKC activation (Figure 4B).
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Figure 4: GPCR signaling pathways. (A) cAMP signal pathway. (1) Receptor activation by an
external stimulus. (2) Gαs or Gαi/o activation. (3) Activation via Gαs or inhibition via Gαi/o
of cAMP production from adenylate cyclase (AC). (4) Activation of protein kinase A (PKA).
(B) Phosphatidylinositol signal pathway. (1) Receptor activation by an external stimuli. (2)
Gαq activation. (3) Hydrolysis of phosphatidylinositol 4,5-biphosphate (PIP2) into inositol
triphosphate (IP3) and diacylglycerol (DAG). (4) Opening of endoplasmic reticulum IP3 gated
calcium channels and PKC activation by DAG.
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Gα12/13-RhoGEF-mediated pathway GPCRs coupling to Gα12/13 activate RhoGTPase nu-
cleotide exchange factors (Rho-GEFs), leading to the activation of members of the Rho family
of small GTPases, and other downstream effectors [51]. For instance, the small monomeric
GTPase RhoA, once bound to GTP can activate various proteins controlling cell cytoskeleton
remodeling, including the rho-associated protein kinase (ROCK) [52]. The latter promotes
actin-myosin contractility and consequent membrane blebbing as will be seen with activation
of the NK1 receptor. All known GPCRs that couple to Gα12/13 also signal through other types
of G proteins, often Gαq/11 [51].
Following its liberation from the heterotrimeric G protein complex, the Gβγsubunit can also
play an important role in GPCR signaling by regulating various ion channels or PLC isoforms
[53].
G-protein signaling is terminated by the hydrolysis of the bound GTP to GDP. The inactive
heterotrimeric G protein returns in its inactive stated by re-association of Gβγ with the GDP-
bound form of Gα [49].
The question of whether the heterotrimeric G protein physically dissociate or not upon GTP
binding is a subject of long-running disputes. Dissociation has initially been proposed based
on in vitro experiments with puriﬁed proteins [54], but its relevance in vivo has been ques-
tioned [55]. Bünemann et al. have shown using ﬂuorescence resonance energy transfer (FRET)
that Gi protein activation in intact cells involves subunit rearrangement rather than disso-
ciation [56]. It has subsequently been suggested that some G protein subunits physically
dissociate in living cells, whereas other heterotrimers may signal without physically disso-
ciating [57]. These contradictory results led to the proposition of a combined model that
defends an equilibrium between dissociated and and intact heterotrimers in the active state
[58] [59]. More recently, Bondar et al. have shown that the presence and localization of the
ﬂuorescent label may have a great inﬂuence on the molecular mechanism of heterotrimeric G
protein activation [60]. Their results revealed that non-modiﬁed Gi proteins dissociate upon
activation, whereas ﬂuorescently labeled heterotrimers dissociate or rearrange depending on
ﬂuorescent protein localization, further feeding the debate on the nature of the activated form
of heterotrimeric G proteins.
GPCR desensitization
Desensitization is the loss of response induced by a prolonged or repeated exposure of the
receptor to an agonist. Desensitization can be: (i) homologous, when the loss of response of
the receptor results only from activation by an agonist of the same receptor; (ii) heterologous,
when activation of a GPCR can lead to the desensitization of another type of GPCR even in the
absence of agonist binding.
This process includes a combination of different mechanisms: uncoupling of the receptor
from heterotrimeric G proteins in response to receptor phosphorylation, internalization of cell
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surface receptors to intracellular compartments, and down-regulation of protein expression,
as well as both the lysosomal and plasma membrane degradation of pre-existing receptors [61].
The time frames over which these processes occur range from seconds (phosphorylation) to
minutes (endocytosis) and hours (down-regulation) [61]. Phosphorylation of speciﬁc residues
within the intracellular loops and C-terminus of the receptor is the ﬁrst step of the desensitiza-
tion process. Receptor phosphorylation is mediated by second messenger-dependent protein
kinases, or by a distinct family of GPCR kinases (GRKs) [62]. Second-messenger dependent
kinases, such as PKA or PKC, are activated by signals resulting from G protein activation such
as increases in the second messengers concentration (Ca2+, cAMP, and DAG). Thus, activa-
tion or PKA or PKC directly uncouples receptors from their respective G proteins. However,
they can also induce heterologous desensitization in receptors other than those activated
[63]. GRKs phosphorylate only activated or agonist occupied conformation of the receptor
(homologous desensitization), thereby promoting binding of an β-arrestin molecule, which
sterically uncouples the receptor from the G protein and leads to receptor desensitization,
internalization, dephosphorylation and recycling of the GPCR. These processes are illustrated
in Figure 5.
β-arresting-dependent signaling
While arrestins were initially named for their ability to shut down (“arrest”) receptor signaling
via G proteins, it is now becoming evident that β-arrestins also function to activate signaling
cascades independently of G protein activation [65, 66]. β-arrestins may act as multi-protein
scaffolds, bringing elements of speciﬁc signaling pathways into close proximity, including in
particular many mitogen-activated protein (MAP) kinases [67]. In addition, nuclear functions
of β-arrestins in transcriptional regulation have been highlighted [68]. Classical and new roles
of β-arrestins in cell signaling have been reviewed by Lefkowitz and coworkers [65, 69].
Interestingly, recent evidences suggest that signaling by internalized GPCRs is not only re-
stricted to mechanisms independent of G protein activation, such as the previously cited
scaffolding by β-arrestins, but that canonical GPCR signaling may also occur from endosomes
[70, 71]. Using a conformation-sensitive biosensor based on a ﬂuorescently labeled nanobody,
Irannejad et al. were able to directly and speciﬁcally visualize β2-adrenergic receptors (β2ARs)
which are in the active state [70]. The biosensor translocated to the plasma membrane upon
β2AR activation and then again to endosomes after ligand-induced internalization of the
receptor, thus revealing a “second wave” of G protein activation.
The NK1 receptor
In this thesis, particular attention will be paid to the neurokinin-1 receptor (NK1R) also known
as tachykinin receptor 1 (TACR1) or substance P receptor. It is a prototypical neuropeptide
GPCR belonging to the rhodopsin-like family (class A) and to the tachykinin receptor subfamily.
The human NK1R consists of 407 amino acid residues, and has a molecular mass of 46 kD [72].
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Figure 5: Regulation of GPCR trafﬁcking by GRKs and arrestins. Agonist (∗) binding leads
to receptor activation, G protein coupling, and signal transduction (step 1). GRKs then phos-
phorylate the agonist-activated GPCR on intracellular domains, initiating arrestin recruit-
ment. Arrestin binding to the receptor inhibits G protein coupling and terminates signaling,
a process termed desensitization (step 2). Receptor/arrestin complexes are then targeted to
clathrin-coated pits, where arrestin forms a multicomponent complex with clathrin, AP-2,
and phosphoinositides, resulting in receptor internalization (step 3). Internalized GPCRs are
sorted (step 4) to either degradation (step 5a) or recycling (step 5b) compartments. Taken
from [64].
It is present in the central nervous system (CNS) and peripheral nervous system (PNS) [73]
where it is involved in a wide variety of different process, e.g. neural signal transmission,
regulation of the intestine, hematopoiesis, nociception and neurogenic inﬂammation [74].
NK1R is therefore an important target for pharmaceutical agents [75, 76]. It is easily expressed
in heterologous systems and several ﬂuorophore labeled agonists and antagonists which bind
with high afﬁnity are known. Therefore, NK1R is particularly well-suited as a model for GPCR
studies.
One of the most potent NK1R natural agonist is an undecapeptide called substance P (SP)
(insert ﬁgure 6) [77]. Binding of SP to NK1R mainly activates Gαq/11, which stimulates the
production of IP3 via PLC, leading to the release of calcium ions from the intracellular stores
[78] as illustrated in ﬁgure 6.
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Figure 6: Main G protein signaling pathways of the NK1 receptor. Upon SP binging, NK1R
couples mainly to Gαq/11, resulting in a transient increase in intracellular calcium concen-
tration. See legend of ﬁgure 4 for a more detailed description of this pathway. In parallel
SP induces changes in cellular morphology that are Gq-independent. These changes are
triggered by activation of the Rho, Rho-associated coiled-coil kinase (ROCK) signaling path-
way, probably via G12/13 proteins. ROCK activates myosin light chain kinase (MLCK) (not
shown) [79], which phosphorylates the MLC. Phosphorylation of this protein activates the
actin-myosin machinery responsible for the formation at the membrane of small spherical
outgrowths known as blebs. The insert in the right upper corner shows the primary structure
of SP (Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2).
The NK1R may also signals though other pathways depending on the nature of the G proteins
(for a detailed review, see [80]), including activation or inhibition of cAMP production by
Gs[81] and Gi [82] proteins, respectively. Nevertheless, the stimulation of cAMP formation
by NK1R agonists is much less efﬁcient than that of IP3 formation and intracellular calcium
increase [81].
Besides the classical Gαq/11 mediated signaling cascade, SP induces cell membrane blebbing
through Rho-ROCK pathway by contraction of the actomyosin cell cortex. This blebbing
phenomenon is not related to apoptosis and is independent of PLC activation, cytosolic
calcium ion increase or PKC activation, but rather induced by the coupling with G12/13 protein
[83]. Cell-derived vesicles originating from membrane blebbing are believed to participate
in communication between distant cells [84], cell movement, cell spreading, and cancer cell
invasion [52].
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Chen et al. have shown that NK1R is present in vesicles derived from membrane blebbing
of HEK293 cells expressing NK1R [84]. In order to prove this, cells expressing a NK1R-GFP
fusion protein or the corresponding non-ﬂuorescent receptor were stimulated with SP and
the resulting microparticles were analyzed by ﬂow cytometry. As expected, microparticles gen-
erated from HEK293-NK1R-GFP cells displayed increased levels of ﬂuorescence, as compared
to those coming from non-ﬂuorescent HEK293-NK1R cells, demonstrating that the NK1R is
present on microparticles [84]. The release of these microparticles may be a form of intercel-
lular communication, with a preponderant role in cancer progression, in particular through
the development of metastasis [85] [86]. This is very interesting, since NK1R antagonists that
effectively block cellular blebbing are known [87, 83]. In fact, it has been shown that L-733,060,
a non-peptide selective NK1R antagonist, reduces SP-mediated migration and invasion of
gastric cancer cells through inhibition of SP binding [88].
Therefore, the NK1R could be a promising new target in cancer treatment. In this regard,
antagonists against the NK1R are of particular interest as they exert three harmonizing actions
as explained by Rosso et al. [85]: “First, they have an antiproliferative action due to the
inhibition of tumor cell growth and induction of apoptosis; second, they inhibit angiogenesis
in the tumor mass; third, they block the migration of tumor cells and thereby inhibit invasion
and metastasis.”. For more details see also [86].
Additional information about the NK1R are presented in chapter 2 (p. 39).
Pentameric ligand-gated ion channels
Ion channels are macromolecular proteins that control the passage of ions across the plasma
membrane. In contrast to simple aqueous pores, gated ion channels are (i) ion selective,
allowing only ions of particular size and charge to pass through and (ii) gated, i.e. they are not
continuously open, but they open and shut transiently. These ion channels may be classiﬁed
by the nature of the stimulus required for their gating.
Ligand-gated ion channels (LGICs), also known as ionotropic receptors, are regulating by
the binding of speciﬁc ligand molecules to the extracellular domain of the channel. Ligand
binding triggers conformational changes in the transmembrane domain, leading to gate
opening and thus allowing the selective passage of speciﬁc ions down their electrochemical
gradient. LGICs diverge from voltage-gated ion channels (which open and close in response
to the voltage across the membrane), metabotropic receptors (which act through second
messengers or G proteins-activated ion channels), or mechanosensitive ion channels (which
opens in response to mechanical deformation of the membrane) [89].
In mammals, LGICs can be classiﬁed into three different superfamilies: the pentameric
ligand-gated ion channels (pLGICs), the tetrameric glutamate receptors, and the trimeric
P2X receptors (ATP-gated channels). Here we will focus on pLGICs, also known as cys-loop
receptors because they contain a characteristic extracellular loop with a pair of disulphide-
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bound cysteines. These receptors are of particular importance for fast signal transduction in
synapses. pLGICs are further subdivided into cation- and anion-selective channels, includ-
ing, respectively, excitatory receptors activated by acetylcholine or serotonin, and inhibitory
receptors activated by γ-aminobutyric acid (GABA) or glycine. These receptors, composed
of ﬁve subunits surrounding a central transmembrane pore, can assemble from ﬁve copies
of a single type of subunit, or more commonly from several different types of subunits. Due
to the numerous subunit types, formation of such hetero-pentamers provides an increased
functional and regulatory diversity, probably to meet the diverse needs for proper synaptic
transmission [90].
Each subunit is composed of a large N-terminal extracellular domain, four transmembrane
alpha helices (M1-M4) and a cytoplasmic loop of variable length between M3 and M4. The
ligand binding sites are located at the extracellular side at the interface between two subunits
[91]. The pair of the disulﬁde-linked cysteines present in the N-terminal extracellular domain
of each alpha subunit is essential for ligand binding [92]. The channel pore is formed primarily
by M2, which dictates ion-selectivity and conductance [91]. The large intracellular linker
between M3 and M4 is believed to be involved in protein-protein interactions modulating
pLGIC activity, assembly and trafﬁcking [93]. TheM3-M4 loop is also thought to play important
role in receptor anchoring to the cytoskeleton and to the postsynaptic membrane [94] [95].
In recent years, the X-ray crystal-structure of several eukaryotic pLGICs have been solved [96]
[97] [98], greatly extending our knowledge of the structure-function relationship of the family.
The 5-HT3 receptor
The 5-hydroxyptamine type 3 receptor (5-HT3R) is a member of the pLGIC receptor super-
family [99]. It is expressed throughout the central and peripheral nervous systems and is
involved in a wide variety of physiological processes. Binding of the neurotransmitter 5-
hydroxytryptamine (serotonin) to 5-HT3R opens the channel, letting Na+ and Ca2+ ions enter
into the cell, which leads to depolarization of the plasma membrane. The 5-HT3R differs
clearly in a structural and mechanistic point of view from the other 5-HT subtypes. Indeed
5-HT type 1, 2, 4, 5, 6 and 7 receptors are all GPCRs [100]. To date, ﬁve different subunits,
named A to E, have been isolated in humans, whereas only A and B subunits are present
in rodents. The A subunit is the only that can form a functional homopentameric receptor.
All the others have to be expressed in combination with the A subunits to form a functional
heteropentamer [101].
Recently, the atomic structure of the mouse 5-HT3R has been solved by X-ray crystallography
(Figure 7), giving new insights for understanding the operating mechanism of receptors of
the pLGIC superfamily [96]. It is the ﬁrst high resolution structure of a mammalian LGIC that
includes the intracellular loop (absent in prokaryotic receptors).
In the CNS, 5-HT3Rs can be localized either on pre- or post-synaptic cells. Post-synaptic
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Figure 7: X-ray structure of the mouse serotonin 5-HT3 receptor. 5-HT3R in complex with
VHH15 viewed parallel to the place membrane. Only two out ﬁve nanobodies are shown (left).
View of the complex from the intracellular side perpendicular to the membrane (right). Taken
from [96].
5-HT3Rs have been shown to be present in GABAergic interneurons where they mediate fast
excitatory synaptic transmission [102]. In pre-synaptic nerve terminals 5-HT3Rs are thought to
be involved in modulation of neurotransmistter release [103]. On a molecular level, activation
of pre-synaptic 5-HT3Rs induce robust increase in presynaptic Ca2+ which, in turn, trigger
the release of neurotransmitters by promoting fusion of synaptic vesicles with the plasma
membrane. In particular, evidence has been provided that 5-HT3R activation facilitate release
of SP in the rat spinal cord [104].
The 5-HT3R, like all receptors having an important role in cell signaling, is involved in many
diseases and disorders and is therefore an important pharmacological target [105, 106]. The
most well established roles of the 5-HT3R are the regulation of gastrointestinal mobility and
the control of emesis. Currently marketed 5-HT3R antagonists are used for the treatment
of chemotherapy-induced and post-operative nausea and irritable bowel syndrome [107].
Promising other therapeutic uses have been reported for treatment of complex psychiatric
disorders such as anxiety and depression, schizophrenia, cognitive dysfunction and substance
abuse and addiction [108, 109]. 5-HT3R antagonists may also be beneﬁcial in rheumatic
diseases as anti-inﬂammatory drugs [110].
Relationship between NK1 and 5-HT3 receptors
In 1983, Coates et al. conducted a survey to identify and rank side-effects perceived by
patients receiving chemotherapy [111]. Nausea and vomiting were classiﬁed as the ﬁrst and
second most severe side effects, respectively. In those days, up to 20% of cancer patients were
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reluctant to take emetogenic but potentially curable chemoterapeutic agents [112]. Since
then, signiﬁcant progress has occurred in antiemetic drug development [113]. Nevertheless
the situation of cancer patients regarding nausea and vomiting is far from comfortable and
improved antiemetic treatments are needed.
Chemotherapy-induced nausea and vomiting (CINV) has been historically categorized as
acute, delayed, or anticipatory depending upon the time period of vomiting. The acute phase
occurs in the ﬁrst 24 hours of administering chemotherapy, the delayed phase persists for 6-7
days after therapy and the anticipatory emesis precedes drug administration (conditioned
response from a previous negative experience with chemotherapy) [114].
According to the established dogma, 5-HT is considered as one of the major actors inducing
the acute vomiting phase after administration of chemotherapy drugs such as cisplatin, while
activation of NK1R by SP is assumed to trigger the delayed CINV phase [115]. It is therefore
not surprising that 5-HT3R and NK1R antagonists are the two major classes of antiemetics
prescribed to prevent CINV [116].
Interestingly, crosstalk between NK1 and 5-HT3 receptor signaling pathways has been reported
by different laboratories [116]. In vitro and in vivo experiments have shown that palonosetron,
a second generation 5-HT3R antagonist with demonstrated efﬁcacy in preventing both acute
and delayed emesis, can inhibit SP-induced calcium release. Because palonosetron does not
bind to the NK1R [117], it is thought that it inhibits the SP response uniquely by its interaction
with the 5-HT3R. Inhibition of these interactions among the crossroads of acute and delayed
emesis may offer new perspectives in the treatment of CINV [116].
In line with this synergistic relationship, SP has been shown to potentiate serotonin-induced 5-
HT3R-mediated currents in rat ganglion neurons, presumably through activation of PKC by the
NK1R [118]. Note that this PKC-mediated up-regulation of 5-HT3R is thought to be caused by
a trafﬁcking mechanism, instead of direct phosphorylation of the receptor protein [119]. Such
NK1R-5-HT3R cross-talk may be of particular importance for regulation of peripheral pain
caused by tissue damage or inﬂammation [118], and might be considered for development of
new therapeutic approaches [120].
Membrane receptor labeling strategies
In order to speciﬁcally detect and identify a membrane protein, e.g. the NK1R or the 5-HT3R,
the latter has to be labeled, generally with a ﬂuorescent probe. Numerous labeling strategies
have been published, including the involvement of antibodies, agonists, antagonists, toxins,
afﬁnity tags, or genetically encoded ﬂuorescent proteins. Together with the choice of the
ﬂuorophore, the choice of the labeling method is of fundamental importance for a successful
observation of the protein of interest. This is particularly true for single-molecule experiments
which require a highly speciﬁc labeling method and very bright and photostable probes that
do not induce protein cross-linking.
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In this thesis, an enzyme-mediated labeling strategy based on a genetically encoded short
peptide tag (chapter 2) and an nanobody-based labeling strategy (chapter 4) have been used to
mark and track individual NK1 and 5-HT3 receptors, respectively. Fluorescent ligands (agonist
or antagonist) binding speciﬁcally these two receptors have also been used.
Fluorescent probes
Numerous different types of probes can be used in combination with the labeling strategies
mentioned above. Initially, micro-sized latex beads and gold-nanoparticles (40-100 nm in
diameter), which could be detected by differential interference contrast microscopy, were
employed to investigate the diffusion of single molecules in the plasma membrane of living
cells [121]. Since 1990, and the demonstration that single ﬂuorophores could be detected
under biologically relevant conditions [122], single-molecule ﬂuorescence-based imaging
has become an indispensable tool in experimental biophysics and new ﬂuorohopres with
increasingly better properties such as ﬂuorescent proteins (FPs), organic dyes and quantum
dots (QDots) have been developed. All these probes have distinct characteristics, which should
be considered to select the most appropriate probe for a given application or experimental
system.
Fluorescent proteins
The discovery and development of the green ﬂuorescent protein (GFP) from the jellyﬁsh
Aequorea victoria [123], in parallel with advances in ﬂuorescence imaging methods and mi-
croscope systems provided unprecedented insights into protein localization, dynamics and
interactions in living cells [124].
Fusion of a FP to the protein of interested is probably the most convenient and non-invasive
way to visualize the latter in a living cell. Because the fusion is achieved at the genetic level,
the labeling is highly speciﬁc and a 1:1 FP/protein stoichiometry is guaranteed. However FPs
suffer of serious disadvantages, particularly a strong photobleaching which limits the total
imaging time of single-molecules to a few seconds. Moreover the signal to noise ratio is in
general relatively low, inducing a localization accuracy well below that of the other ﬂuorescent
probes discussed below [125].
Quantum dots
QDots are ﬂuorescent semiconductor nanocrystals with an extraordinary potential in bio-
logical detection and imaging [126, 127]. These nanocrystals demonstrate unique optical
properties allowing measurements at the single-molecule level with high signal-to-noise ratio.
Unlike organic ﬂuorophores and ﬂuorescent proteins, QDots do not rapidly photobleach,
thereby allowing to record much longer trajectories. Furthermore QDots have been estimated
to be up to 20 times brighter and almost indestructible as compared to traditional ﬂuores-
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cent reporters [128], enabling a better localization accuracy, and allowing imaging on fast
time-scales [129].
Their nanometric size induces a quantum conﬁnement that provokes a discretization of the
energy levels, giving them a unique physical property: the color of the emitted light depends
on the size of the QDot; the larger the QDot, the more is the emitted light shifted to the
red/infrared (Figure 8B) [130]. Combined with a broad absorption spectrum, this make QDots
particularly well suited for multi-color observations [131, 132].
QDots are generally composed of a core and a shell of semi-conductor material (e.g. a core of
CdSe and a shell of ZnS). Biocompatibility of QDots is crucial for biological applications. In
this sense, different coatings with amphiphilic polymers, phospholipids and small molecules
have been developed and tested successfully on living cells [128]. Coated QDots can be further
functionalized with antibodies, proteins (e.g. streptavidin) or targeting ligands, allowing
speciﬁc labeling of proteins of interest (Figure 8A) [133].
BA
Figure 8: Structure and properties of QDots probes. (A) Schematic representation of a QDot.
The inorganic cadmium selenide (CdSe) core nanocrystal and zinc sulﬁde (ZnS) shell (in
red) can be coated with different organic molecules (in gray) such as peptides, amphiphilic
micelles or polymers, providing colloidal stability in biological buffers. Key features of the
surface coating include PEG to reduce nonspeciﬁc interactions and reactive groups to enable
conjugation of biomolecules such as DNA, streptavidin or antibodies. GFP and ﬂuorescein
dye are shown for size comparison. Scale bar, 5 nm. Taken from [129]. (B) Size-tunable
ﬂuorescence properties and spectral range of QDots. Absorption and emission spectra of
different QDots (upper panel). Photo of QDot dispersions plotted above, excited at 365 nm
with a UV source (lower panel). Taken from [134].
Despite their relative large size (6-60 nm), the inﬂuence of QDots on the diffusion coefﬁcient
of the targeted membrane proteins is negligible because the viscosity of the plasma membrane
is much higher (100- to 1000-fold) than that of the extracellular medium, thus the membrane
is dominating the receptor diffusion. However this is not necessarily the case in a restricted
environment, like the synaptic cleft [135].
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Themost commonly cited disadvantage of QDots in the literature after the size, is their blinking
behavior, or ﬂuorescence intermittency [136]. This phenomenon of random switching be-
tween ON (bright) and OFF (dark) states may cause difﬁculties in monitoring protein dynamics
at the single-molecule level, especially in establishing correspondence between consecutive
frames in tracking experiments [137]. Speciﬁc tracking algorithms are required [138, 139, 140].
However, there is some hope that blinking can be suppressed by improved surface chemistries
or addition of reducing agents [127]. Wang and coworkers reported a new generation of
gradient-based QDots that exhibits continuous, non-blinking photoluminescence and that
can be produced in smaller sizes (5-7 nm) [141]. These novel non-blinking nanocrystals may
enable substantial advances in single-molecule imaging and tracking. On the other hand,
blinking can be seen as an advantage as it provides a criterion for distinguishing single QDots
from aggregates. Furthermore, the blinking behavior of QDots can be exploited to achieve
super-resolution. For example, SOFI (super-resolution optical ﬂuctuation imaging), a tech-
nique based on the temporal and spatial cross-correlation analyses of ﬂuorescence ﬂuctuation,
take advantage of the blinking mechanism to achieve background free, contrast enhanced 3D
super-resolution imaging [142].
For an extensive review about QDots see [143].
Organic dyes
The principal advantage of organic dyes is their small size (∼0.5 nm) and their highly controlled
stoichiometry in the complex with the recetpor, thereby lowering the risk of interference with
the proper biological function of the protein of interest. They also provide a higher photo-
stability and brightness than FPs [144]. For a review, see [145].
The development of new organic dyes with improved photostability and brightness which
could potentially rival with QDots is ongoing [146].
Measuring protein diffusion using ﬂuorescence microscopy
The plasma membrane has a fundamental role in many essential cell functions. All these
functions are performed by an extremely complex network of interacting proteins and lipids
present on or near the cell surface. The direct study of surface molecules association is often
not possible. However, important information about their interactions may be obtained via
their mobility behavior over time and space. Interestingly, the lateral mobility of membrane
molecules can inﬂuence the location and the manner these associations occur. Therefore,
studying mobility is essential for the membrane function and organization comprehension.
Fluorescence-microscope-based methods to investigate both membrane organization and
dynamics include FRAP, FRET, ﬂuorescence correlation spectroscopy (FCS) [147] and single-
molecule/particle tracking techniques. In the following, focus will be on single-molecule
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imaging and tracking.
General aspects of single-molecule ﬂuorescence imaging
The saga of single-molecule experiments is relatively recent. One of the ﬁrst breakthroughs in
this ﬁeld was achieved by Moerner in 1989 with the optical detection of a single ﬂuorophore
molecule in a solid at cryogenic temperature [148]. Before that, direct observation of single
molecules was thought to be impossible. In the 90s, considerable advances in experimental
instrumentation and in particular in the sensitivity of detectors allowed the detection and
tracking of single ﬂuorophores in the plasma membrane of living cells [121]. This resulted
in the appearance of new concepts accounting for the dynamic organization of biological
systems, a good example being the picket-fence model proposed by Kusumi and discussed in
the ﬁrst part of this introduction (p. 5).
The diffusion coefﬁcient is the most common and accessible parameter to account for the
mobility of molecules in membranes. Its determination does not necessarily require single-
molecule resolution. Techniques such as FRAP and FCS have been extensively used to measure
dynamic molecular behavior both in puriﬁed systems and in cells [149, 150]. However the
diffusion coefﬁcients obtained provide diffraction-limited information and reﬂect only the
average diffusive behavior of an ensemble of molecules. In single-molecule experiments
the properties of individual molecules are investigated, offering more valuable and precise
information for the comprehension of the biological system. This is particularly true in a
complex and heterogenous system like the plasma membrane where individual proteins can
behave very differently and are not synchronized. In this case, ensemble measurements are
only providing average properties and only experiments at the single-molecule level are able
to reveal the presence of sub-ensembles. This can be of critical importance for the elucidation
of the dynamic organizing principles of the plasma membrane underlying the molecular
mechanism that regulate signal transduction [27].
A key challenge in single-molecule experiments is to distinguish photons coming from a single
ﬂuorescent probe from those coming from the noise. This requires well prepared samples
combined with a high-end measurement setup. A schematic view of the experimental setups
used in this thesis for imaging and tracking single molecules can be found in Appendix A.
Spatial resolution and localization precision
In conventional light microscopy the spatial resolution is limited by diffraction [151]. The
lateral resolution limit (Δr) corresponds to the minimum distance that two point-source
objects have to be in order to discriminate (resolve) the two sources from each other. The
Abbe’s criterion stipulates that light with wavelengthλ, traveling through a lens with numerical
22
General introduction
aperture NA, will make a spot with radius:
Δr = 0.5 · λ
NAobj
(1)
Later this criterion was reﬁned by Rayleigh (Eq. 2). This is illustrated in ﬁgure 9B.
Δr = 0.61 · λ
NAobj
(2)
For visible light microscopy the resolution limit is therefore on the order of 200-250 nm.
However this limit is not a drawback for single-molecule imaging and tracking. It only requires
that the molecules we observed must be separated by a distance larger than the resolution.
This can be easily achieved by adjusting the concentration of the labeled species. Because
singlemolecules can be localizedwith a precision better than the diffraction-limited resolution,
single-molecule microscopy can be considered as subdiffraction imaging technique, even if
the measurement is performed with a standard optical microscope.
Figure 9: Airy diffraction pattern and the limit of resolution. Airy patterns in the xy plane
(bottom) and intensity distribution plot along x-axis (top) for various angular separation of two
point sources. (A) The points are fare apart, the patterns are well resolved. (B) The points are
at an angular separation just satisfying the Rayleigh criterion (the maximum of one diffraction
pattern coincide with the ﬁrst minimum of the other), the patterns are just resolved. (C) The
points are closer than in the Rayleigh criterion, the patterns are not resolved. Adapted from a
personal work of Spencer Bliven published on commons.wikimedia.org
A 2D-Gaussian is usually used to approximate the intensity proﬁle of the diffraction-limited
spot (the point spread function or PSF). For a perfect optical system, based on circular ele-
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ments, the PSF forms a so-called Airy pattern (Figure 9). The central Airy disc contains 84% of
the total energy in the pattern. Hence, the position of a single molecule can ben determined
with high accuracy by the maximum of the Gaussian proﬁle approximating the Airy disc. As the
PSF describes the probability distribution of the emitted photons, the localization accuracy
(σr ) will increase as the number of detected photons (N) increases (equation 3). Hence, the
choice of the probe is of paramount importance (see Fluorescent probes, p. 19).
σr ≈ λ/2
N
(3)
The typical localization accuracy in a SMT experiment is 5-50 nm depending on the choice of
label [152].
Single-molecule tracking (SMT)
SMT allows the direct observation of the movement of individual single-molecules over time
with subdiffraction-limited spatial resolution. To achieve this, a limited number of molecules
of interest are speciﬁcally labeled with e.g. gold nanoparticles, QDots, or organic dyes. In this
way, trajectories of individual proteins diffusing in the plasma membrane of living cells can
be reconstructed with nanometer accuracy and millisecond temporal resolution. Thereby
substantial information on relevant biological questions such a signal transduction or synaptic
regulation can be elicited [25, 135, 147].
Tracking process
In a SMT experiment, a low density of labeledmolecules of interest is essential for the Airy disks
do not overlap. After recording a time-lapse image sequence of the single moving particles, the
latter are localized in each successive frames based on their the local ﬂuorescence intensity
maxima. Reconstruction of the molecular trajectories is achieved by connecting the positions
of the localized particles (Figure 10).
For the tracking procedure to be successful and not too time consuming, relatively complex
mathematical algorithms are required. A home-written software running on Igor Pro (Wave-
metrics) and developed by my colleague J. Piguet was used to extract the diffusional behaviors
of the molecules. A detailed description of this software can be found in reference [153].
Membrane diffusion models
As a result of thermal agitation, plasma membrane components constantly undergo random
collisions which result in stochastic movements. In a two-dimensional system such as the
plasma membrane, the position (r) of a molecule performing Brownian motion as a function
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Figure 10: Processing of SMT data. Reconstitution of diffusing QDots trajectories is made
in three distinct steps. (i) Acquisition: raw data collected by the detector are exported as a
2D-series of images encoding ﬂuorescence intensity and position. (ii) Localization: on each
frame, the center of each diffraction-limited spot which correspond to an individual QDot is
located by Gaussian ﬁtting of the ﬂuorescence intensity proﬁle. The localization accuracy, σ,
depends according to eq. 3 strongly of the total number of detected photons, N, during the
measurement. (iii) Tracking: Trajectories are formed by linking ﬂuorescent spot positions in
successive frames. Taken from [129].
of time (t) can be described by the following probability distribution function:
p(r, t )dr = 1
4πDt
·exp
(
− r
2
4Dt
)
·2πrdr (4)
where D is the diffusion coefﬁcient (units μm2/s).
The average position of the molecule is obviously zero, the maximum of the Gaussian proﬁle
being time independent and remaining at the origin, <r>=0. The most common and trivial
way to analyze SMT data is by calculating the mean square displacement (MSD), which
corresponds to the average area that a particle may cover in a given time t lag. In case of
two-dimensional free diffusion, the particle explore an increasingly larger area with time and
the MSD increases linearly with time according to:
< r 2 >=MSD = 4Dtlag (5)
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In living cells, however, the diffusion of plasma membrane molecules is rarely totally free
because of transient transport, molecular crowding, transient conﬁnement, and other barriers
or obstacles that make the apparent diffusion constant time-dependent. In the general
case where nothing is assumed about the nature of the constraints, the diffusion is termed
anomalous and the is characterized by a power law of exponent α in equation (6) [154].
MSD = 4Dtαlag (6)
The exponent α can be considered as the reﬂection of the deviation from free Brownian
diffusion (α = 1 for Brownian motion). A negative curvature of the MSD (α < 1) arises from
obstacles or transient interactions that hinder the diffusion, whereas a positive curvature (α >
1) results generally from active cellular transport processes.
The anisotropic nature of the cell plasma membrane make the anomalous diffusion dependent
on the time-scale. At short times, anomalous diffusion matches free diffusion, while at larger
times-scales the diffusion appears slower.
In the case of conﬁned diffusion, the MSD plot tends towards a horizontal asymptote, whose
level is proportional to the conﬁnement size. Equation (7) is simpliﬁed function for conﬁned
diffusion in a square region of size Lc with impermeable barriers:
MSDconﬁned =
L2c
3
·
(
1−exp
(−12 ·D · tlag
L2c
))
(7)
Directed motion is observed for particles diffusing in a ﬂow or undergoing active transport, for
example due to the action ofmolecularmotors [155]. It is described by a quadratic dependance
of the MSD on t lag:
MSDdirected = 4Dtlag + v2t2lag (8)
where the added term characterized the directed motion, with v as the mean velocity of the
transport.
Analysis of single-molecule trajectories
As already mentioned, the most common way to analyze a single-molecule trajectory is by
plotting the mean square displacement (MSD) for each time interval (t lag). The MSD for a
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Figure 11: Plot of mean square displacement (MSD) versus time for the different modes of
motion that can be observed in the cell plasma membrane. A diffusion coefﬁcient D of 0.002
μm2/s, a conﬁnement length Lc of 800 nm, a anomalous coefﬁcient α of 0.8, and a velocity v
of 0.04 μm/s were used for the generation of the different MSD curves based on equations (5)
to (8).
trajectory of N frames is calculated using equation (9) [137], where r is the position of the
particle.
MSD(ntlag)=
1
N −n
N−n∑
i=1
[(
r
(
(i +n)tlag
)− r (i tlag))2
]
(9)
Looking at the shape of the MSD curve may give us information about the mode of motion
(Figure 11) in order to classify the trajectories. However, analysis of single trajectories by using
MSD vs t lag is only valid for single molecules moving with constant diffusion parameters,
which is almost never the case in reality.
A method frequently used for ﬁtting SMT experimental data is to assume that the particles
are free to diffuse at very short times. By ﬁtting only the ﬁrst few MSD data points, an initial
diffusion coefﬁcient (e.g. D1−10), which is independent of the inﬂuence of diffusion barriers or
obstacles in the plasma membrane, is obtained.
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Moment scaling spectrum In spatially complex systems such the plasma membrane of
living cells, the MSD often does not increase linearly in time and in this case Brownian
motion will be better described by anomalous diffusion. In equation (6), the measure of the
nonlinearity of the MSD with time is introduced by the parameter α [154]. Ferrari et al. [156]
extended this measurement by introducing a non-negative integer, ν, as an extra parameter
(Eq. 10). The MSD corresponds to the particular case where only the second order moment is
analyzed (ν=2 and γν=α). A plot of γν vs ν is called moment scaling spectrum (MSS) [156]. The
MSS method is particularly well suited to categorize the single-molecule trajectories according
to their mode of motion: the MSS slope (SMSS), also called Hurst parameter, represents a
value that can be directly associated with the mode of motion experienced by the molecule
of interest. A SMSS value of 0.5 deﬁnes a Brownian diffusion, whereas conﬁned and directed
motions are characterized by values below and above 0.5, respectively. Values equal or close to
zero describes immobility.
< r ν >∼ tγν (10)
The MSS method offers two major beneﬁts over the classiﬁcation with the MSD: (i) a smaller
error due to the better linearity of the MSS and (ii) a clearer distinction between the different
modes of motions [156, 157].
Trajectory segmentation An additional difﬁculty in single-molecule trajectory analysis ar-
rises when the tracked particle change its mode of motion during the acquisition process. This
is particularly true for long-term measurements, with e.g. quantum dots.
The changes of diffusion mode within single trajectories can be taken into consideration using
a segmentation procedure, in which the original trajectories are sequentially cut into shorter
sub-trajectories. The segmentation algorithm used in the present thesis (developed by my
colleague Dr. Joachim Piguet) uses a sliding window of 100-frames moving along the trajectory
in steps of one frame and cutting at each step to obtain segments. In this way, a 1000-frames
trajectory will results in 901 segments, the ﬁrst ranging from 0 to 100, the second from 2 to 101,
and so on until the last frame of the trajectory is reached. Each segmented sub-trajectories
thus obtained are then analyzed as independent trajectories. This allows to drastically increase
the amount of information that can be extracted from a single trajectory and in particular, to
follow the temporal evolution of the diffusion and to take into account transitions between
diffusion modes.
Mobility pattern To visually represent the diffusion data collected during this work, the two
central mobility parameters D1−10 and SMSS , calculated for each individual segment, were
displayed as a two-dimensional probability density function (Figure 12). This novel high-
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content graphical representation of single-molecule mobility was termed “mobility pattern”.
It allows to visualize and analyze the complex information contained in a particular SMT
experiment, by resolving highly heterogeneous receptor populations as well as following their
evolution over time. This method of analysis enables to easily deﬁne and classify the diffusing
molecules into different types according to their mobility regime, facilitating substantially
comparison of results obtained under different experimental conditions.
Figure 12: Mobility pattern. By displaying the Hurst parameter (SMSS) against the diffusion
coefﬁcient (D1−10) using a continuous probability density function, highly heterogenous NK1R
populations can be resolved: (*) receptors freely diffusing in the membrane, (**) receptors
conﬁned in domains. The color code scales with the indicated frequency (a.u.) of states.
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1 Labeling of NK1 receptor for single-
particle tracking in living cells
The general goal of this thesis is to study the dynamics of membrane receptors at the nanome-
ter scale and on the single-molecule level in the plasma membrane of living cells. In this
respect labeling of the receptor of interest with a suitable ﬂuorescent probe is the ﬁrst step
towards this goal. In this ﬁrst chapter focus will be on the NK1R (see Introduction, p.12), and
more precisely on its labeling with quantum dots with a view to tracking individual receptors.
1.1 ACP labeling
Numerous methods for post-translational labeling of proteins exist [158]. Among them en-
zymatic labeling reactions are especially attractive because they can afford covalent labeling
with high speciﬁcity. In this work a method based on the acyl carrier protein (ACP) and de-
scribed by George et al. [159] has been extensively used. The method consists of the enzymatic
modiﬁcation of the ACP by phosphopantetheine transferase (PPTase), leading to the transfer
of 4’-phosphopantetheine from co-enzyme A (CoA) to a serine residue of ACP, which is ge-
netically fused to the protein of interest [159]. A large variety of chemical compounds such as
ﬂuorophores, afﬁnity ligands but also quantum dots can be attached to CoA and subsequently
covalently transferred to fusion proteins on cell surfaces [160] [161].
The ACP labeling method offers numerous advantages, including [159, 161]:
• High speciﬁcity of the reaction.
• Only the proteins correctly incorporated into the plasma membrane are labeled (this
prevents background ﬂuorescence arising from non-correctly folded receptors inside
the cell).
• Straightforward control of the labeling density (critical for single-molecule experiments).
• Small and covalent attachment linker.
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Furthermore it has been shown that the ACP-NK1R fusion protein was activated by binding its
natural agonist, substance P (SP), at a similar effective concentration (EC50) as the wild type
receptor [162]
1.2 Labeling of NK1 receptor with quantum dots
As discussed in the introduction, the labeling of the protein of interest is one of themost critical
step in determining the success and quality of a single particle tracking (SPT) experiment.
Interaction of QDots with biological samples on a glass surface often implies nonspeciﬁc
binding, which can ruin the experiment. Although there is no universal solution to this
problem, several measures such as PEGylation of the QDot surface as well as correct choice
of buffer conditions have proven to be effective to reduce nonspeciﬁc interactions [129];
addition of 1-2% of bovin serum albumin (BSA) to the labeling medium may greatly improve
the labeling speciﬁcity [137] but also signiﬁcantly enhance stability and photoluminescence
quantum yield of QDots [163].
Another difﬁculty in single-molecule labeling is to obtain an appropriate density of speciﬁcally
labeled molecules under relevant experimental conditions. SPT experiments need a very
low concentration of labeled molecules (i.e. a few molecules per cell) to allow resolution of
single peaks and to minimize crossing trajectories, which make the subsequent analysis more
complex and time-consuming. Optimal labeling conditions have to be found by adjusting
concentration, incubation time, temperature or media composition [129]. Other important
parameters to consider are the QDot conjugate afﬁnity and the expression level of the target.
Therefore, ﬁnding a proper labeling procedure can be laborious.
While labeling methods are well-established for standard organic dyes, it is quite different for
QDots. In order to ﬁnd the best way to attach a QDot to the NK1R, three different strategies
(illustrated in ﬁgure 1.1), have been explored.
1.2.1 Experimental procedures
All the preliminary experiments described below were accomplished in Shimon Weiss’ Lab-
orartory at UCLA with the help of Dr. Xavier Michalet and Dr. Jianmin Xu. CoA-biotin and
PPTase were obtained from Dr. Ruud Hovius (LCPPM, EPFL).
Cell culture
Labeling experiments were performed on adherent human embryonic kidney (HEK) 293 cells
stably expressing ACP-NK1R fusion protein. This stable cell line was established by Dr. Bruno
Meyer [164]. Wild type HEK293 cells were used as negative control (NK1R not endogenously
expressed). Cells were cultured in Dulbecco’s modiﬁed Eagle’s medium (DMEM)/F12 with
GlutaMAX-I (Invitrogen) supplemented with 10% newborn calf serum (NBCS) (Sigma-Aldrich)
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Figure 1.1: Strategies for NK1R labeling with QDots. (A) SP-conjugated QDots were applied
on cells stably expressing NK1R. (B) CoA-functionalized QDot was transferred to the ACP tag
fused to the N terminus of the receptor. The reaction is catalyzed by phosphopantetheine
transferase (PPTase). (C) In a ﬁrst step (i) biotinylated CoA was transferred to the ACP tag. In a
second step (ii) SA-coated QDot was bound to the receptor’s biotin.
at 37°C in a humidiﬁed 5% CO2 atmosphere. ACP-NK1R expressing cells were maintained
in presence of 200 μg/ml hygromycin B (Calbiochem). Cell cultures were split at regular
time intervals and plated in antibiotic-free complete medium in LabTek 8-well chambered
coverglass (Nunc) at a density of ∼250’000 cells/ml. Labeling and single-molecule imaging
experiments were performed in phosphate buffered saline (PBS) buffer (pH 7.4) supplemented
with 1% (wt/vol) BSA (Sigma) 24 to 48h after platting.
SP-conjugated QDots
Commercial QDots (QDot 625 antibody conjugation kit from Invitrogen) were conjugated to
SP via BS3 (bissulfosuccinimidyl suberate) as crosslinker. This homobifunctional crosslinker
has two identical reactive groups (NHS ester) at each end which react with primary amines
to form an amide bond. SP-conjugated QDots were prepared by a two-step reaction (Figure
1.2): (i) BS3 linker was attached to the QDot via an amine group present at the surface of
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the QDot; (ii) The other end of the BS3 linker was reacted with one of the primary amine
of SP. The reaction was quenched using hydroxylamine. This results in QDots comprising
several SP molecules. However we can assume that there is only one QDot per SP molecule;
the two reactable primary amines of SP are too close to each other (see insert Figure 6, p.14)
for accommodating two QDots. Cells were incubated in PBS-BSA with SP-QDots at room
temperature. Different concentrations of SP-QDots and incubation times have been tested.
Figure 1.2: Functionalization of QDots with SP using bis[sulfosuccinimidyl] suberate (BS3),
a crosslinker containing an amine-reactive NHS-ester at each end that can react with the
primary amines present on the QDots and SP molecules.
ACP labeling with CoA-QDots
Preparation of QDot-CoA is shown in Figure 1.3. Brieﬂy, the amines on the surface of the QDot
were functionalized with a bifunctional linker (sulfo-SMCC). Then CoA was directly linked
to the QDot via a maleimide-thiol reaction . Unreacted maleimide groups were capped with
β-mercaptoethanol. Two different CoA:QDot ratios (3:1 and 30:1) have been tested. Labeling
was performed by incubating the cells in PBS-BSA with 10 mM MgCl2, 1 μM PPTase and 0.2
nM CoA-QDots for 20 minutes at 37°C.
Figure 1.3: Synthesis of CoA-conjugated QDots. After functionalization of
amines on the QDot surface with a bifunctional linker (sulfosuccinimidyl-4-(N-
maleimidomethyl)cyclohexane-1-carboxylate), CoA is directly linked to the QDot via a
maleimide-thiol reaction. Unreacted maleimide groups are capped with β-mercaptoethanol.
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ACP labeling with CoA-biotin and streptavidin-coated QDots
The last labeling strategy which was tested was a two-step post-translational labeling proce-
dure based on the strong interaction between biotin and streptavidin [165]. In the ﬁrst step,
the transfer of the phosphopantetheine moiety of a biotinylated CoA (CoA-biotin, 5 μM) to
the ACP tag fused to NK1R was catalyzed by PPTase (20 min, 37°C). The cells were washed
three times with PBS-BSA. In a second step QDot 625 streptavidin conjugate (SA-QDot) (Invit-
rogen) was bound to the receptor’s biotin (5 min, RT). Different concentrations of SA-QDot
(picomolar to nanomolar) have been tested.
Single-particle imaging and tracking
A custom-built TIRF microscope based on a Zeiss Axiovert 100 inverted microscope equipped
with a front-illuminated EMCCD was used to perform single-molecule imaging of QDot-
labeled NK1Rs. A detailed description of the setup can be found in [166]. The ventral plasma
membrane of the cells was imaged at room temperature (∼ 27°C). Diffusion trajectories (30 s)
of individual receptors were recorded at a rate of 33 Hz. For measurements on activated
receptors, SP was added to the sample at a ﬁnal concentration of 100 nM. Single-molecule
QDot-NK1R trajectories were extracted using a homemade software (named “AsteriX”) devel-
oped in Labview by Dr. Xavier Michalet (UCLA).
1.2.2 Results and discussion
In order to evaluate the speciﬁcity of the different strategies for NK1R labeling (Figure 1.1),
HEK293 cells not expressing the receptor were used as negative control.
For SP-QDots (Figure 1.1A) no signiﬁcant differences were observed between NK1R-expressing
cells and the control. In both cases, many visually immobile QDots were present. This labeling
strategy would have been potentially less interesting than the two others because it would
have allowed to track only activated receptors.
For CoA-QDots (Figure 1.1B), non-speciﬁc labeling was also extremely high. Yet the suitability
of this technique have been successfully demonstrated on different ACP fusions of receptor
proteins in living cells [161]. However in our case, despite numerous trials with different
CoA:QDot ratios, the speciﬁcity of the reaction has proved to be insufﬁcient for reliable
tracking of single receptors. The reasons of this failure remain unclear. This labeling method
would have been particularly attractive due to the small size of the QDot-receptor linker and
to the possibility to study the dynamic of receptors before and after activation.
The use of SA-QDots (Figure 1.1 C) requires ﬁrst to attach a biotin molecule to the protein of
interest. Here ACP labeling with CoA-biotin was used. Subsequently different concentrations
of SA-QDots have been tested. At nanomolar concentration, the receptor-bound fraction is
too high for SPT (Figure 1.4 A). Picomolar concentration of SA-QDot resulted in the presence
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of about ten visible QDots on a single-cell surface, allowing the tracking of individual receptors
(Figure 1.4 B) . As a control, cells stably expressing ACP-NK1R but not labeled with CoA-biotin
were incubated with SA-QDots. At nanomolar concentration only very few immobile QDots
were observed Figure 1.4 C) , whereas no QDot was present at the cell surface when using
picomolar concentration (Figure 1.4 D). Similar results were obtained with HEK293 cells
devoid of expressed ACP-NK1R but treated with CoA-Biotin and PPTase and incubated with
SA-QDots. The ideal labeling concentration of SA-QDots for the tracking of individual NK1R is
picomolar concentration range; under these conditions, unspeciﬁc labeling is negligible.
Figure 1.4: Post-translational labeling of NK1R with QDots in living HEK293 cells. Each
panel shows TIRF microscope images on the left, and the corresponding transmission images
(wide-ﬁeld) on the right. (A) Cells stably expressing ACP-NK1R labeled with CoA-biotin and
incubated with ∼0.5 nM streptavidin-coated QDot (SA-QDot). (B) Cells stably expressing ACP-
NK1R, labeled with CoA-biotin and incubated with∼5 pM SA-QDot. (C) Cells stably expressing
ACP-NK1R, not labeled with biotin (control experiment) and incubated with ∼0.5 nM SA-
QDot. (D) Cells stably expressing ACP-NK1R, not labeled with biotin (control experiment) and
incubated with ∼5 pM SA-QDot.
This method offers the possibility to investigate the inﬂuence of agonist binding on receptor’s
mobility. A quick visual comparison of the traces recorded before and after agonist-induced
receptor activation, of which an arbitrary but nonetheless representative selection is shown in
ﬁgure 1.5, clearly indicates an increased conﬁnement of activated NK1Rs.
Fitcher et al. showed that QDots are suitable probes for monitoring and quantifying GPCR
endocytosis at the single-receptor level in live cells [167]. The fact that QDots do not impact to
the internalization process has been conﬁrmed for the NK1R as shown in ﬁgure 1.6.
The major drawback of SA-QDots is that they could potentially induce receptor cross-linking
(i.e. one QDot binds to several receptors). This issue is discussed in chapter 3 (p. 63).
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Figure 1.5: Representative trajectories for single QDot-labeled ACP-NK1Rs in the plasma
membrane of living HEK293 cells, in the absence (top line) and presence (bottom line) of the
agonist SP.
Figure 1.6: Confocal ﬂuorescence micrographs showing HEK293 cells stably expressing ACP-
NK1R labeled with CoA-biotin and incubated with 1 nM of SA-QDot 655 before (left) or after
addition of 100 nM SP (right). Scale bars: 20 μm.
1.2.3 Conclusion
Among the different strategies that have been assessed for NK1R labeling with QDots, the two-
step labeling procedure based on the biotin-streptavidin couple has proved to be the best by far
in term of labeling speciﬁcity. The high speciﬁcity and efﬁciency of the ACP labeling reaction,
combined with the very strong biotin-streptavidin interaction and the high photostability and
brightness of QDot probes allow to precisely control the amount of labeled receptors and to
record long single-molecule trajectories with very high accuracy. This provides a good starting
point for a more quantitative analysis of the immobilization effect observed upon stimulation
of the NK1R with SP and for the identiﬁcation of the interactions that cause the latter (chapter
2).
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2 Single-molecule microscopy deciphers
the relation between mobility and
signaling of the NK1 receptor in living
cells
2.1 Abstract
Lateral diffusion enables efﬁcient interactions between membrane proteins, leading to signal
transmission across the plasma membrane. An open question is how the spatio-temporal
distribution of cell surface receptors inﬂuences the transmembrane signaling network. Here
we addressed this issue by studying the mobility of a prototypical G protein-coupled receptor,
the neurokinin-1 receptor, during its different phases of cellular signaling. Attaching a single
quantum dot to individual neurokinin-1 receptors enabled us to follow with high spatial and
temporal resolution over long time regimes the fate of individual receptors at the plasma
membrane. Single receptor trajectories revealed a very heterogeneous mobility distribution
pattern with diffusion constants ranging from 0.0005 to 0.1 μm2/s comprising receptors freely
diffusing and others conﬁned in 100–600 nm sized membrane domains, as well as immobile
receptors. A two-dimensional representation of mobility and conﬁnement resolved two major,
broadly distributed receptor populations, one showing highmobility and low lateral restriction,
the other low mobility and high restriction. We found that about 40% of the receptors in the
basal state are already conﬁned in membrane domains and are associated with clathrin. After
stimulation with an agonist, an additional 30% of receptors became further conﬁned. Using
inhibitors of clathrin-mediated endocytosis, we found that the fraction of conﬁned receptors
at the basal state depends on the quantity of membrane-associated clathrin and is correlated
to a signiﬁcant decrease of the canonical pathway activity of the receptors. This shows that
the high plasticity of receptor mobility is of central importance for receptor homeostasis and
ﬁne regulation of receptor activity.
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2.2 Introduction
Membrane receptors are of utmost importance for cellular signaling, transferring the in-
formation of extracellular stimuli into intracellular responses. In this context, their lateral
distribution and mobility in the plasma membrane play a critical role as random or directed
movements in the membrane plane bring signaling partners efﬁciently into transient or stable
contact [6, 8, 168, 169]. A fundamental issue of modern quantitative cell biology is to under-
stand how the complex, highly dynamic spatial distribution of components of the plasma
membrane inﬂuences central cellular signaling processes [170, 171, 20]. Single-molecule
optical imaging, more speciﬁcally single-particle tracking (SPT), is ideally suited to establish
a tomogram of the distribution of individual plasma membrane components over time and
space, revealing the full complexity of individual signaling reactions that would be hidden in
ensemble measurements [172].
Here we concentrate on seven-transmembrane domain (7TM) receptors, also known as G
protein-coupled receptors (GPCRs). GPCRs establish the largest family of cell-surface re-
ceptors converting extracellular signals into intracellular responses. As they are involved in
many central physiological processes they are also among the most important targets for
drug development [46, 173, 174, 175]. After activation by extracellular stimuli, GPCRs are
typically desensitized, internalized and recycled. These processes occur from seconds (phos-
phorylation) over minutes (endocytosis) to hours (down-regulation) [61]. In this context the
clathrin-mediated endocytosis (CME) machinery is essential for maintaining proper function
of GPCRs on the cell surface [176]. All this yields an amazing diverse network of intracellular
signaling reactions and in turn a complex receptor pharmacology.
Here we used the human neurokinin-1 receptor (NK1R) as a prototypical GPCR to investi-
gate its lateral distribution in living cells at different states before and after activation. The
NK1R is activated by tachykinin neuropeptides and belongs structurally to the rhodopsin-like
GPCR family [72]. It mediates a wide variety of neuronal and metabolic processes, and is an
important drug target for treating diseases such as depression or cancer [80].
The NK1R mediates classical membrane signaling reactions, summarized in Figure 2.1: After
binding its natural agonist, the undecapeptide substance P (SP), the NK1R activates its G
protein Gαq , which in turn activates phospholipase C, leading to Ca2+ release from the endo-
plasmic reticulum [77, 78]. Thereafter, the NK1R is phosphorylated and binds β-arrestin
to target the receptor to clathrin-coated pits (CCPs) and activating the CME machinery
[177, 178, 179, 180, 181]. Endocytosis of the β-arrestin-NK1R complex occurs within the
ﬁrst minute of agonist exposition [72, 182]. Internalization of the NK1 receptor is ﬁnalized
about 10 minutes later [73, 183, 184]. NK1R trafﬁcking is inﬂuenced by SP; high SP concen-
tration induces receptor internalization to perinuclear sorting endosomes, whereas low SP
concentration induces receptor translocation to early endosomes followed by rapid recycling
coinciding with the recovery of SP binding sites at the cell surface [80, 185]. Furthermore, a
NK1R subpopulation can be desensitized and resensitized without leaving the vicinity of the
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plasma membrane [186].
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Figure 2.1: Internalization and recycling of NK1R at the cell plasma membrane. The NK1R
can be located in different regions of the plasma membrane and in intracellular endosomes:
1. Nanometer-sized membrane domains. 2. Clathrin-related region 3. Clathrin pre-pits.
4. Clathrin-coated pits closed by dynamin. 5. Clathrin-coated vesicles. 6. Early, late, or
perinuclear endosomes. 7. Lysosomes. 8. Recycling vesicles. NK1R can be recruited in the
different regions described above: I. Receptor exchanges between clathrin-related region
and free membrane. II. After agonist binding, receptor is phosphorylated leading to the
recruitment of β-arrestin. The receptor is targeted to clathrin pre-pits. III. Receptor-clathrin
complex is bound to dynamin dependent invaginating regions. IV. Receptor is internalized in
clathrin-coated vesicles, which are then transformed to early endosomes. V. SP is removed
from NK1R in late endosomes, where either, in step VI, SP and a fraction of the receptors
is degraded in lysosomes or, in step VII, a fraction of the receptors is recycled to the cell
membrane.
In living 293T cells, individual NK1Rs show highly heterogeneous diffusion properties [187].
In general, the median diffusion coefﬁcient of a NK1R population rapidly decreases after
stimulation with SP [188]. Immobile or conﬁned receptors are already present in the basal
state, i.e. in absence of activating ligands, suggesting that SP inﬂuences the equilibrium
between different receptor states [187], which in turn would modulate the interaction between
particular signaling proteins concentrated in membrane nano- or micro-domains [162].
The spatial organization and the mobility of GPCRs in the cell membrane are of utmost
importance to ensure correct signal transduction, fast desensitization and endocytosis of
the receptor. Here, we addressed these issues by attaching a single quantum dot (QDot)
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to individual NK1Rs, which enabled us to follow with high spatial and temporal resolution
over long time regimes the fate of individual receptors at the cell’s plasma membrane. By
characterizing simultaneously the mobility and conﬁnement of each individual receptor it was
possible to detect and distinguish different, highly dynamic receptor populations in the plasma
membrane and correlate them with distinct steps of the GPCR mediated transmembrane
signaling cascade.
2.3 Experimental procedures
2.3.1 Cell culture
Adherent 293T cells, stably expressing the NK1R genetically fused with an acyl-carrier protein
at the extracellular N-terminus (ACP-NK1R) [162], were grown at 37°C in DMEM/F12 (Life
Technologies) supplemented with 10% v/v newborn calf serum (NBCS) (Sigma-Aldrich) and
200 μg/ml hygromycin B (Sigma-Aldrich) in a humidiﬁed atmosphere with 5% CO2. Cells were
seeded 24-48h before microscopy experiments in 8-well plates (Lab-Tek Nunc, Naperville,
IL) in growth medium without antibiotics. Single receptors were imaged in colorless DMEM
supplemented with 15 mM HEPES (Life Technologies) without antibiotics or serum.
2.3.2 Addition of chemicals to cells
NK1Rs were activated adding freshly prepared SP to the extracellular medium (Tocris, Bristol,
UK). Nocodazole (AppliChem, Darmstadt, Germany) was used at 1 μM and cytochalasin B
(Sigma-Aldrich) at 20 μM. Dyngo-4a and PitStop 2 (Abcam, Cambridge, UK) were applied at 30
μM and Dynasore (Sigma-Aldrich) at 80 μM. Methyl-β-cyclodextrin (mβCD, Sigma-Aldrich)
was used at 10 mM, and Y-27632 (Tocris) at 10 μM. All chemicals, except SP were added to the
extracellular medium 20–30 minutes before SPT measurements.
2.3.3 siRNA knockdown of clathrin
Clathrin depletion was achieved using ON-TARGETplus SMARTpool siRNAs (Dharmacon/GE
Healthcare, Amersham, UK) against the human clathrin heavy chain 1 (CLTC) with the fol-
lowing target sequences: (i) 5’-GAG AAU GGC UGU ACG UAA U-3’, (ii) 5’-UGA GAA AUG UAA
UGC GAA U-3’, (iii) 5’-GCA GAA GAA UCA ACG UUA U-3’, and (iv) 5’-CGU AAG AAG GCU
CGA GAG U-3’. Transfection of siRNAs (15 pmol/well) was performed with lipofectamine 2000
(Invitrogen, Carlsbad, USA) according to the manufacturer’s instruction. SPT measurements
were performed 60 h after transfection.
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2.3.4 Receptor function assay
The NK1R mediated activation of the Gαq pathway was assayed measuring the intracellular
Ca2+ response after SP addition. 293T cells stably expressing ACP-NK1R were seeded into
a 96-well plate (Perkin-Elmer, Waltham, MA) and grown in DMEM/F12 10% NBCS for 24h.
Cells were loaded with Fluo4-NW (Life Technologies) in Hanks’ balanced salt solution-HEPES
according to manufacturer instructions. After 30 min at 37°C, cells were placed in a FLEX
Station (Molecular Devices, Sunnyvale, CA). A ﬁrst operation cycle was used to add buffer,
nocodazole, cytochalasin B, Dyngo-4a, PitStop 2, or mβCD at appropriate concentrations. In
a second operation cycle, SP was added at concentrations ranging from 10−12 to 10−7 M to
obtain a dose-dependent response curve, from which maximum responses were extracted.
2.3.5 Receptor labeling
293T cells stably expressing ACP-NK1R were washed once with DMEM/F-12 medium 10%
NBCS supplemented with 1% w/v bovine serum albumin (BSA). Labeling was performed
by incubating the cells for 15 min at 37°C in DMEM/F-12 10% NBCS containing 1% BSA, 10
mM MgCl2, 1 μM PPTase (4’-phosphopantetheinyl transferase), and 5 μM CoA-biotin. Af-
ter incubation and prior to the second step of labeling, cells were washed three times with
DMEM/F-12 10% NBCS supplemented with 1% BSA. Cells were then incubated for 5 min at
room temperature with 10 pM streptavidin-coated CdSe-ZnS core-shell QDots 655 (Invitrogen,
Life Technologies) in Dubelcco’s PBS containing Ca2+ and Mg2+ and supplemented with 1%
BSA. Prior to SPT measurements, cells were rinsed three times in colorless DMEM comple-
mented with 1% BSA to remove unbound QDots. To account for cell variability and avoid
NK1R unrelated effects, experiments on inactive NK1R state without addition of chemicals
have been performed systematically before each new experiment.
2.3.6 Microscopy
For single-molecule microscopy, cells were mounted on a modiﬁed epi-ﬂuorescence wide-
ﬁeld microscope (Axiovert 200, Zeiss, Feldbach, Switzerland). To observe QDots 655, light of a
488 nm Obis diode laser (Coherent Inc., Santa Clara, CA) was directed by a dichroic mirror
(Q645LP, Chroma Corp, McHenry, IL) into the microscope objective (C-Apochromat 63X/1.2
numerical aperture water corrected, Zeiss) to illuminate a 15-μm diameter region of the
sample. Fluorescence was collected by the same objective, passed through a ﬁlter (HQ710/100,
Chroma) and a 1.6x Zeiss Optovar, and imaged on an electron-multiplying charge-coupled
device camera (Ixon 887BV, Andor Technology, Belfast, UK). Single-molecule trajectories were
recorded at a frequency of 30 Hz with excitation intensities around 0.1 kilowatt/cm2 for 33
s. For confocal scanning microscopy, cells were mounted on Zeiss LSM 510 microscope
(Zeiss). QDots were excited with the 488 nm line of an Argon ion laser. Fluorescence signal was
acquiredwith a 63X, 1.2 numerical aperturewater immersion objective (Zeiss), ﬁltered through
an HFT 488/561 dichroic mirror and a 650 nm long pass ﬁlter (both Zeiss), and detected with
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an avalanche photodiode (Perkin-Elmer).
2.3.7 Single-molecule tracking
Image sequences were treated using a home-written software in Igor Pro (Wavemetrics, Lake
Oswego, OR). Each image of a single-molecule time series was restored using a noise ﬁlter
to remove: (i) Long-range structures from inhomogeneous laser proﬁle, detector ﬂuctuation
and autoﬂuorescence regions. (ii) Short-range discretization noise and charge-coupled device
spikes [189]. Local maxima were determined on the ﬁltered image. Each local maximum was
then ﬁtted using a 2-dimensional Gaussian ﬁt. Size, shape and ﬂuorescence intensity time
proﬁle of a ﬁtted ﬂuorescent peak was veriﬁed to match single-molecule features. Selected
ﬂuorescence peaks were then linked over an image series to obtain trajectories. To avoid bias
in subsequent steps of analysis only cells with more than 90% of approved visible labels were
considered.
2.3.8 Analysis of individual trajectories
Diffusion coefﬁcient, length of conﬁnement region, moment scaling spectrum and velocity
were calculated from individual trajectories as described elsewhere [190]. To extract a maximal
amount of information, long trajectories were segmented using a sliding window of 100 frames.
Each of the segmented trajectories was treated as an individual and analyzed to obtain ﬁve
mobility related features:
1. Initial diffusion coefﬁcient D1−10 [187, 121]. This initial diffusion is computed by ﬁtting
the ﬁrst 10 time intervals of a standard mean square displacement (MSD) versus time
lag (tl ag ) curve. It corresponds to a maximal time interval of 200 ms, during which the
diffusion is less affected by long-range features.
2. Hurst parameter, SMSS [157].
3. Length, L, which is the diagonal of the smallest rectangle containing 95% of the point
position.
4. Asymmetry [191].
5. Efﬁciency [192].
These features were then used to construct a vector, which described with high speciﬁcity the
mobility state of the particular trajectory segment.
2.3.9 Population analysis
D1−10 and SMSS values characterize the mobility properties of individual receptors and, by ex-
tension, those of a receptor population. These two values were obtainedwith two independent
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calculations from the same dataset. Median values of D1−10 and SMSS were calculated for
each experimental condition. Boxplots were then computed to obtain population extent and
95% conﬁdence interval (notches) using R (R Foundation for Statistical Computing). D1−10
and SMSS values were used to compare different experiments. Two-dimensional probability
functions of D1−10 and SMSS were determined using the values obtained with the segment
feature analysis. 2D mobility patterns were obtained using the kde2d function of R on D1−10
and SMSS . This two-dimensional kernel density estimator was then used to establish a mobility
pattern for each condition. Bandwidths of 0.11 on the x-axis, corresponding to log10(D1−10)
and 0.03 on the y-axis, corresponding to SMSS were used, unless otherwise stated.
2.3.10 Classiﬁcation of individual trajectories
Trajectories were classiﬁed according to two methodologies: (i) Ensemble analysis, calcu-
lating the proportion of trajectories exhibiting deﬁned characteristics from the complete
two-dimensional probability function described above. (ii) A priori, or single-trace, classiﬁca-
tion assigning a single trace to a category depending on the values of the mobility parameters
described above. For a priori classiﬁcation, a linear support vector machine (SVM) has been
used. Three homogenous sets of real trajectories (shown on Figures 2.2C, 2.2E, and 2.2G)
served as training set. The SVM was based on a 4-dimensional vector comprising D1−10, SMSS ,
asymmetry and efﬁciency. The training set was composed of 6969 type I, 5500 type II, and 7524
type III segments of trajectories. The same classiﬁcation machine was used to construct a time
dependent distribution. A sliding time window of 160 s was used to extract the evolution of
the mobility parameters in time. The classiﬁcation was performed for each time frame using
the same support-vector machine as above.
2.3.11 Dimension of conﬁned regions
The dimension of a conﬁned region (L) in the case of restricted receptor diffusion is not a
straightforward value to obtain. It is generally estimated by ﬁtting a MSD vs tl ag curve of
either a single trajectory or an ensemble of trajectories using a complete [29] or a simpliﬁed
[7] function of tl ag . Here we chose a simpliﬁed deﬁnition of the conﬁnement length, as the
diagonal of the smallest rectangle enclosing 95% of the trajectory. This deﬁnition has been
retained to avoid artifacts due to noise and interdependence of L and D.
2.4 Results
2.4.1 Heterogeneous mobility of the NK1R in the plasma membrane of 293T cells
To track a particular receptor equipped with one QDot, we used a 293T cell line stably express-
ing ACP-NK1R [187, 162]. The ACP-NK1R was labeled by the following sandwich method. We
ﬁrst covalently linked CoA-biotin to the ACP tag of the receptor and then bound to the biotin a
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streptavidin-coated QDot [159]. Labeling with QDots did not prevent receptor endocytosis.
The highly speciﬁc labeling of a few NK1Rs at the plasma membrane of a living cell, allowed us
to follow trajectories of individual NK1Rs over time periods between 30 seconds and 2 minutes
at 33 ms temporal resolution (see supplemental Movie S1)1.
Trajectories of single receptors diffusing on the dorsal cell membrane were obtained from
time-lapse series of 1000 ﬂuorescence images recorded at 30 frames per second using a wide-
ﬁeld epi-ﬂuorescence microscope. NK1R showed ﬁve distinguishable mobility regimes in the
plasma membrane; (i) free Brownian diffusion, (ii) slow diffusion in conﬁned regions, (iii) fast
diffusion in conﬁned domains, (iv) directed motion, and (v) immobile receptors (Figure 2.2A).
Here, we determined the short-term diffusion coefﬁcient, D1−10, and the Hurst parameter,
SMSS [157]. D1−10 is related to the physical properties of the surrounding membrane and the
interaction of the receptor with its close environment [188, 162, 29]. SMSS describes the overall
mode of motion; values below 0.5 are typical for conﬁned diffusion, values equal or close to
zero represent immobile molecules, Brownian movements are characterized by SMSS values
around 0.5, whereas directed movements show SMSS values above 0.5 [157].
In order to augment the information content extracted from each single-molecule trace, a win-
dow of 100 frames was moved along the trajectory, and each resulting segment was analyzed as
an independent trajectory. The two central parameters D1−10 and SMSS were calculated from
each segment and displayed as a two-dimensional probability density function, named “mo-
bility pattern”. This novel representation method allowed for resolving highly heterogeneous
receptor populations as well as for following their evolution over time.
Receptors in the basal state (Figures 2.2A-B) displayed distinct diffusion modes. Freely diffus-
ing receptors had characteristic diffusion coefﬁcients D1−10 between 0.016 and 0.05μm2/s and
SMSS values > 0.3. Importantly, receptors with SMSS values between 0.3 and 0.5 diffuse in the
plasma membrane without boundaries even if they display anomalous behavior. Receptors
with conﬁned diffusion showed diffusion coefﬁcients D1−10 ranging from 0.002 to 0.02 μm2/s
and SMSS values spread between 0.1 and 0.3. Typically conﬁned diffusion was restricted to do-
mains of 120–550 nm size and in a few cases to 70–800 nm domains. Receptors were assigned
as immobile when their D1−10 values were lower than 0.002 μm2/s and their SMSS values lower
than 0.1. Fast-conﬁned receptors had diffusion coefﬁcients larger than 0.02 μm2/s and SMSS
< 0.15. Less than 2% of NK1Rs exhibited directed motion, and these comprised two distinct
cases: receptors transported in the membrane plane outside of domains or receptors diffusing
freely in moving nanodomains.
To simplify the analysis, receptors were classiﬁed into three categories: type I comprised the
freely diffusing and directed receptors, type II the conﬁned and immobile receptors, and type
III the fast-conﬁned receptors as described above. Representative traces of each type and their
corresponding mobility pattern are shown on Figures 2.2C-H. The interchange rate between
1http://www.jbc.org/content/290/46/27723/suppl/DC1
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Figure 2.2: Heterogeneous diffusion of NK1R in the plasma membrane of 293T cells. Dif-
fusion trajectories of individual NK1Rs labeled with QDots 655 are measured by SPT in the
plasma membranes of the cells. The mobility patterns of the receptor are presented as two-
dimensional probability density functions calculated from measured trajectories, a selection
of which are shown in C, E, and G. SMSS of the trajectory segments are plotted versus D1−10.
D1−10 and SMSS describe the diffusion coefﬁcient and the type of motion of the receptor,
respectively. (A) Single-receptor trajectories from a single cell obtained at 30 Hz with an
acquisition time of 29 ms. (B) Mobility pattern of 1342 individual receptors measured in the
basal state. Boxes indicate the regions of the different mobility types, depicted in D, F and H.
(C) Typical traces of type I diffusion with average D1−10 > 0.008 μm2/s and SMSS > 0.25. The
12 trajectories depicted were selected from a collection of 633 individual receptors satisfying
these conditions. (D) Mobility pattern of type I receptors of which selected trajectories are
shown in C. (E) Typical traces of type II diffusion with average D1−10 < 0.002 μm2/s and SMSS
< 0.1. The 12 trajectories depicted were selected from a collection of 483 individual recep-
tors satisfying these conditions. (F) Mobility pattern of type II receptors of which selected
trajectories are shown in E. (G) Typical traces of type III diffusion with average D1−10 > 0.02
μm2/s and SMSS < 0.15. The 12 trajectories depicted were selected from a collection of 131
individual receptors satisfying these conditions. (H) Mobility pattern of type III receptors
of which selected trajectories are shown in G. (I) Closer view of a typical type III receptor
trajectory. The color code scales with the indicated frequency (a.u.) of states.
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these three different receptors was very low, less than 3%, during 30 s measurement windows
corresponding to an interchange rate of 10−3 s−1.
The mobility pattern of NK1Rs in the basal state exhibited two clear distinct peaks (Figure
2.2B) corresponding to freely diffusing (type I) and to restricted (type II) receptors, respectively.
For each populations, both diffusion coefﬁcients and Hurst parameters did not show a normal
distribution; instead, the logarithm of D had a bimodal and S had multimodal distribution
(Figure 2.3A). The median and the range of these distributions served as a basis for comparing
receptor mobility between different experiments. Although diffusion trajectories of individual
NK1Rs were highly heterogeneous in 293T cells (Figure 2.2A), the mobility pattern of the
ensemble population (Figure 2.2B) was totally reproducible over days of measurement under
identical experimental conditions.
In the following, the NK1R mobility was characterized either globally or as type I, II or III.
The overall parameters were obtained by including all the trajectories measured during an
experiment, whereas the values for the particular mobility types were obtained considering
only the trajectories of the corresponding type.
2.4.2 Receptor immobilization after activation
To probe the effect of an activating ligand on NK1R mobility, the cells were stimulated with var-
ious amounts of the natural agonist SP. After addition of SP, the portion of receptors conﬁned in
nanometer-sized domains signiﬁcantly increased. This immobilization effect is clearly visible
by comparing supplemental Movie S2 and supplemental Movie S32, which were recorded
in absence or presence of SP, respectively. Figures 2.3A and 2.3B show the two-dimensional
distribution of D1−10 and SMSS values for single receptor trajectories before and after receptor
activation, respectively. Figures 2.3C and 2.3D show the corresponding mobility patterns
evaluated as described before. The mobile receptor population (type I, high values of D1−10
and SMSS) decreased in favor of the conﬁned receptor population (type II, low values of D1−10
and SMSS), in which the immobile receptor subpopulation (D1−10 < 2·10−3 μm2/s, SMSS <
0.1) increased substantially. This transition occurred in the ﬁrst minutes after addition of SP.
Interestingly, this immobilization depended on the concentration of added SP with an EC50 of
about 100 pM for the average SMSS (Figure 2.3E).
2.4.3 Temporal classiﬁcation of trajectory segments
To reach an accurate and reliable classiﬁcation of trajectories, we applied a machine learning
evaluation procedure. The support-vector machine (SVM) was based on the four mobility
parameters D1−10, SMSS , efﬁciency and asymmetry (for deﬁnition see “Experimental proce-
dures”), which were calculated from segments of archetypal trajectories. SVM was run for both
basal and activated states of the receptors. The dataset of receptors in the activated state was
2http://www.jbc.org/content/290/46/27723/suppl/DC1
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Figure 2.3: (ﬁgure on previous page). Effect of SP binding on NK1R diffusion in 293T cells.
SMSS vs D1−10 plot of 1207 individual receptors in absence of agonist. Probability density func-
tion (pdf) of D1−10 (bandwidth = 0.11 in the logarithmic scale) (top) and of SMSS (bandwidth =
0.03) (right). (B) Same representation as in A of 433 NK1R in presence of 83 nM SP. (C) Mobility
pattern of NK1R in the basal state. (D) Mobility pattern of NK1R in the ﬁrst 30 minutes after
addition of 83 nM SP. Color code at the bottom of C and D scales with the indicated frequency
(a.u.) of states. (E) Dependence of NK1R immobilization on SP concentration. The average
value of the Hurst parameters SMSS corresponds to the average receptor mobility for each
concentration. An EC50 ≈ 100 nM SP was calculated for the mobility change by ﬁtting the
SMSS vs SP concentration data with a standard Hill function. (F) Support-vector machine
classiﬁcation of trajectory segments according to the three deﬁned types, before and after
addition of 83 nM SP. (G) Time-evolution of the three classes of trajectory segments. A sliding
time window of 160 seconds has been used to obtain the support-vector machine results in
F and G. SP was added at t = 0. The evaluated time frames comprised between 21’747 and
68’834 trajectory segments. Error bars represent S.D.
limited to trajectories acquired during the ﬁrst 1000 s after addition of SP. An increase of 27%
of type II receptor population correlated with a decrease of 23% of type I receptor population,
rapidly followed receptor activation, whereas the fraction of type III receptors remained stable
(Figure 2.3F). To follow the intrinsic changes of receptor mobility over time, we measured
the respective fractions of the mobility types during 1000 s at basal state (Figure 2.3G). No
signiﬁcant changes were detected during this time interval. After addition of SP, the type II
receptor population increased rapidly with a correlated decrease of type I receptor population.
30 minutes after activation, type I receptors recovered to its initial level, while the type III re-
ceptor population started to increase signiﬁcantly (Figure 2.3G). This distinct fraction showed
a high mobility (D>0.02 μm2/s) and a strong conﬁnement (SMSS < 0.2) (Figure 2.2H) in circular
200 - 600 nm sized domains (Figures 2.2G and 2.2I). After long-term exposition to the agonist,
the relative majority of receptors showed typical type III trajectories (Figures 2.2G and 2.3G).
2.4.4 Contribution of the Rho/ROCK pathway
This intriguing behavior of type III receptors may correspond to receptors diffusing in mem-
brane blebs or microvesicles. Actually, in 293T cells, activation of NK1R with SP stimulates
formation of membrane blebs and microvesicles derived from the cell membrane through
the Rho/ROCK pathway [83]. To investigate the effect of this secondary pathway on receptor
mobility and localization, Y-27632, a Rho-associated coiled-coil kinase inhibitor was added to
the cells prior to SP addition. After stimulation with SP in the presence of Y-27632, receptors
were immobilized in the plasma membrane as in the absence of the inhibitor, with a similar
shift from mobile (type I) to immobile and conﬁned (type II) receptor populations (Figures
2.4A and 2.4C). After 60 minutes of combined SP and Y-27632 exposition (Figure 2.4D), the
NK1R mobility was comparable with that of the basal state (Figure 2.4A). Importantly, the
fast-conﬁned receptor population (type III) did not increase, unlike in the absence of the
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Rho/ROCK pathway inhibitor (Figure 2.4B). This shows that the type III receptor population is
directly linked to the Rho/ROCK signaling pathway.
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Figure 2.4: Long-term evolution of NK1R mobility after SP exposition and Rho-ROCK path-
way inhibition. (A) Mobility pattern of the NK1R in the basal state, measurements started 1.5h
after receptor labeling. (B) Measurements started 1.5 after addition of 83 nM SP and 1.5h after
receptor labeling. (C) Measurements started just after SP addition and 30 min after labeling in
presence of Y-26732, a Rho/ROCK pathway inhibitor. (D) Measurements started 1h after SP
addition and 1.5h after receptor labeling in presence of Y-26732, a ROCK inhibitor. The color
code scales with the indicated frequency (a.u.) of states.
2.4.5 Role of the cytoskeleton on NK1R conﬁnement
To determine the origin of the important fraction of conﬁned receptors (type II) at the basal
state, we ﬁrst investigated the role of the cytoskeleton and cholesterol, two key players often
associated with protein compartmentalization in the plasma membrane.
GPCRs can interact directly or indirectly with the cell’s cytoskeleton [176, 193, 194]. Here we
probed the inﬂuence of the cytoskeleton onNK1Rdiffusion using cytoskeleton-depolymerizing
toxins. To investigate the interactions of the NK1R with microtubules, the cells were incubated
with nocodazole, an anti-neoplastic agent interfering with microtubule polymerization. This
resulted in a signiﬁcant decrease of the overall mobility of the NK1R, as seen by the median
short-term diffusion coefﬁcient (Figure 2.5E). This effect correlated with a signiﬁcant increase
of type II fraction, while the diffusion coefﬁcient of the type I receptors remained unaffected
(Figures 2.5A-B).
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Figure 2.5: Modulation of NK1R mobility in 293T cells by cytoskeleton disruption and
cholesterol depletion. (A) Mobility pattern of the NK1R in the basal state. This control
pattern has been established using all basal state measurements performed before addition
of chemicals. (B) Mobility pattern after addition of 1 μM nocodazole. (C) Mobility pattern
after addition of 20 μM cytochalasin B. (D) Mobility pattern after addition of 10 mM mβCD.
The color code scales with the indicated frequency (a.u.) of states. (E) Boxplot of D1−10 in
presence of chemicals modifying cell cytoskeleton and membrane cholesterol content: basal
state receptors (n=314), in presence of nocodazole (n=294), cytochalasin B (n=146) and mβCD
(n=60). The median is drawn as a horizontal line. Notches indicate the 95% conﬁdence interval
of the median. Boxes represent the interquartile ranges of the distribution. Signiﬁcance has
been determined by a Wilcoxon ranking test on the distribution where each condition is
compared with the related basal state, with − indicating no difference, and ∗∗∗ p < 0.001 with
the null hypothesis (H0) that population A is not different from population B. Trajectories of
the receptors in the basal state were measured on the same cells before addition of chemicals.
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The hindered and heterogeneous mobility observed in SPT experiments can stem from con-
tacts of the receptors with the actin based membrane skeleton [195, 10]. To probe the existence
of such interactions, cells were treated with cytochalasin B, an inhibitor of actin ﬁlament poly-
merization. Cytochalasin treatment did not signiﬁcantly change the overall median diffusion
coefﬁcient (Figure 2.5E). More speciﬁcally, D1−10 of the type I receptor population remained
unaffected. However, the population of conﬁned receptors increased substantially, resulting
in signiﬁcantly lower SMSS values as revealed by the associated mobility pattern (Figure 2.5C),
in which the type III receptor population increased and the type I decreased. Importantly,
neither the population nor the mobility features of type II receptors were affected by actin
depolymerization. Theses results indicate that the restricted mobility of the NK1R is not due
to direct interactions with the cell’s cytoskeleton.
2.4.6 Decrease of receptor mobility after cholesterol depletion
Cholesterol has been shown to play a role in the localization of NK1R in plasma membrane
domains [196]. To investigate the effect of cholesterol content in the plasma membrane on
NK1R diffusion, the cells were treated with methyl-β-cyclodextrin (mβCD). We found that
membrane cholesterol depletion by mβCD decreased the overall mobility of the receptor
(Figure 2.5E). In particular, we observed two independent effects: (i) a shift of the mobility
pattern toward conﬁned diffusion of type II (Figure 2.5D), and (ii) a decrease of the median
diffusion coefﬁcient of the type I receptor population to 0.011μm2/s, which differs signiﬁcantly
from the values observed for receptors in the basal state (0.016 to 0.025 μm2/s).
2.4.7 NK1R interaction with clathrin
The NK1R is recycled through the CME pathway [184]. Since the role of cytoskeleton and
cholesterol appeared to be of minor importance in receptor conﬁnement, we investigated
the inﬂuence of clathrin on NK1R mobility. Three different CME inhibitors have been used to
block formation and internalization of CCPs at different steps: (i) PitStop 2, which impairs
association of amphiphysins with the clathrin terminal domain [197], (ii) Dynasore, which
inhibits dynamin 1 and 2 GTPase activity [198], and (iii) Dyngo-4a, a potent Dynasore analogue
[199]. Addition of each inhibitor signiﬁcantly shifted receptor mobility towards restricted
motion (Figures 2.6A-D). The type II receptor population increased without modiﬁcation of
the overall shape of the distribution, namely without a shift towards the subpopulation of
immobile receptors. No signiﬁcant differences were observed between the three different
inhibitors. The mobility patterns were stable for more than one hour. During this timeframe,
no noteworthy changes in cell morphology were observed.
In presence of the CME inhibitors, stimulation of the cells with SP (83 nM) further reduced
NK1R mobility. Indeed the short-term diffusion coefﬁcients (D1−10) of single trajectories
signiﬁcantly decreased (Figure 2.6E), while the conﬁnement was not affected, as illustrated by
the stable values of SMSS (Figure 2.6F).WithDyngo-4a (Figure 2.6B) andDynasore (Figure 2.6D)
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Figure 2.6: Modulation of NK1R mobility in 293T cells by CME impairment. (A) Mobility
pattern of NK1R in the absence of CME inhibitors before (top) and after (bottom) addition of
83 nM SP. (B) Mobility pattern of NK1R in presence of 30 μM Dyngo-4a before (top) and after
(bottom) addition of SP. (C) Mobility pattern of NK1R in presence of 30 μM PitStop2 before
(top) and after (bottom) addition of SP. (D) Mobility pattern of NK1R in presence of 80 μM
Dynasore before (top) or after (bottom) addition of SP. The color code scales with the indicated
frequency (a.u.) of states. (E), (F) Boxplots of the NK1R mobility parameters from full-length
receptors trajectories after addition of CME inhibitors before and after activation with SP. The
median is drawn as a horizontal line. Notches indicate the 95% conﬁdence interval of the
median. Boxes represent the interquartile ranges of the distribution. Signiﬁcance has been
determined by a Wilcoxon ranking test on the distribution where each condition is compared
with the related basal state, with − indicating no difference, ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗
p < 0.001 with the null hypothesis (H0) that population A is not different from population B.
(E) Boxplot of the diffusion coefﬁcient D1−10 in absence of CME inhibitors (n=217, with SP
n=104), after addition of 30 μM Dyngo-4a (n=163, with SP n=155), after addition of 30 μM
PitStop 2 (n=127, with SP n=60), and after addition of 80 μM Dynasore (n=91, with SP n=110).
(F) Boxplot of the Hurst parameter SMSS for the same trajectories as in E.
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the type I receptor population signiﬁcantly decreased after activation. The type II receptor
population increased and displayed a broader distribution of D1−10. In both experiments a
signiﬁcant amount of receptors diffused in domains. Cells treated with PitStop 2 (Figure 2.6C)
also displayed a strong reduction of type I receptor population, whereas the distribution of
type II receptor population showed a narrower distribution around immobile receptors (D1−10
< 0.002 μm2/s, SMSS < 0.1) compared to the two dynamin inhibitors.
To investigate the inﬂuence of clathrin on the receptor further, we speciﬁcally depleted the
cellular content of clathrin using siRNA. We found an increase of the overall mobility of NK1R
in the plasma membrane; the mobility pattern showed a signiﬁcant increase of the type I
receptor population (Figures 2.7A-B). Furthermore, receptor conﬁnement decreased markedly
with a 37% higher value for SMSS (Figure 2.7D), while D1−10 increased only slightly (Figure
2.7C).
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Figure 2.7: Mobility of NK1R in the plasma membrane of 293T cells after siRNA-mediated
clathrin depletion. (A) Mobility pattern of NK1R in non-transfected control cells. (B) Mobility
pattern of NK1R after siRNA knockdown of the clathrin heavy chain. For both A and B,
bandwidths are D1−10 = 0.21 in the logarithmic scale and SMSS = 0.09. The color code scales
with the indicated frequency of states (a.u.). (C) Boxplot of the NK1R diffusion coefﬁcient
D1−10 and (D) of the Hurst parameter SMSS in absence (n=61) and in presence (n=23) of
siRNA against clathrin. The median is drawn as a horizontal line. Notches indicate the 95%
conﬁdence interval of the median. Boxes represent the interquartile ranges of the distribution.
Signiﬁcance has been determined by a Wilcoxon ranking test on the distribution where each
condition is compared with the related basal state, with − indicating no difference, and ∗∗ p <
0.01 with the null hypothesis (H0) that population A is not different from population B.
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2.4.8 Impairment of NK1R-mediated Ca2+ signaling
The impact of the different chemical modulators used in the present study on NK1R activity
was probed using a standard Ca2+ assay based on the ﬂuorescent indicator Fluo-4 NW. Mi-
crotubule or actin ﬁlament disruption with nocodazole or cytochalasin B, did not affect the
cellular Ca2+ response induced by SP, whereas removal of cholesterol with mβCD almost abol-
ished Ca2+ signaling (Figure 2.8A). Addition of Dyngo-4a and PitStop 2, which down-regulates
CME, also led to a signiﬁcant decrease of the Ca2+ response (Figure 2.8B). These results point
out the importance of cholesterol but also clathrin in the regulation of NK1R activity.
To evaluate the ability of NK1R to bind SP in presence of the CME inhibitors, a ﬂuorescent
derivative of SP (SP-Cy5) was added to the cells, and binding of the ﬂuorescent agonist was
monitored using confocal microscopy. Dyngo-4a, PitStop 2 and Dynasore did not prevent
SP-Cy5 binding (Figures 2.8C-E).
2.5 Discussion
Here, we have investigated the mobility features of the NK1 receptor with an unprecedented
level of mechanistic understanding. We used mobility patterns as a new, high-content
graphical representation of single-molecule mobility. This representation is based on a two-
dimensional density function of the short-range diffusion coefﬁcient D1−10, versus the mo-
bility parameter SMSS , which is directly associated with the mode of motion of the receptor.
This enabled us to visualize and analyze the complex information contained in a particular
experiment within a single graph, facilitating substantially comparison of results obtained
under different experimental conditions. Moreover, this method of analysis allowed us to
easily deﬁne and classify the diffusing particles into different types according to their mobility
regime.
Our study revealed that in spite of the very broad distribution of the mobility and sizes of mem-
brane conﬁnement, the overall NK1R mobility pattern remains highly reproducible between
different days of experiment. This suggests the presence of a very distinct and stable network of
functional interactions between the receptor and other cellular components. As presented in
the results section, NK1R can be classiﬁed into three major classes. Receptors assigned to type
I are free to diffuse in the cellular membrane. Their general diffusion properties are accessible
by other measurement techniques such as ﬂuorescence recovery after photobleaching (FRAP)
or ﬂuorescence correlation spectroscopy (FCS). The overall features of type I receptors are
comparable to those observed by single-molecule tracking of other GPCRs [188, 200, 201, 202].
The low SMSS values measured here correlate with a restricted diffusion of the NK1R. A similar
behavior was observed for other receptors in living cells and is often explained by multiple
effects such as the rough, irregular shape of the plasma membrane, transient interactions
with other membrane proteins, the heterogeneous composition of the plasma membrane, or
the recruitment in caveolae [187, 26, 203, 204, 205]. The diffusion coefﬁcients of GPCRs we
and others have observed in the membranes of living cells are considerably lower than those
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Figure 2.8: Efﬁciency of the Gαq activation pathway in 293T cells after cytoskeleton disrup-
tion, cholesterol depletion and CME inhibition (A and B) and capacity of the NK1R to bind
SP in presence of the CME inhibitors (C-E). (A) Intracellular Ca2+ responses measured with
Fluo-4 in the presence of 83 nM of agonist SP before and after addition of (i) nocodazole
which disrupts microtubules, (ii) cytochalasin B which prevents F-actin ﬁber formation, and
(iii) mβCD which depletes cholesterol from the plasma membrane. (B) Intracellular Ca2+
responses before and after CME impairment by PitStop 2 and Dyngo-4a. (C-E) Fluorescence
confocal micrographs showing 293T cells stably expressing ACP-NK1R labeled with CoA-
alexa488 before (left), and after adding 50 nM of the agonist SP-Cy5 (right), in absence of CME
inhibitor (C), in presence of Pitstop 2 (D), or Dyngo-4a (E). Scale bars: 20 μm.
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of other membrane proteins of similar size or that of rhodopsin as an example of a class A
GPCR in pure lipid bilayers [206, 27]. The use of QDots as ﬂuorescent label to track individual
receptors allowed us to validate in a accurate and reliable manner previous single-molecule
diffusion measurements using organic dyes by Prummer et al. [187]. Consequently, the use of
QDots does not interfere with the receptor’s diffusion properties.
Low diffusion coefﬁcients are often explained by direct interactions of the membrane protein
of interest with components of the cytoskeleton [207, 208, 209]. According to the picket-fence
model [10], drug treatment causing actin depolymerisation should result in an increased
receptor diffusion due to the reduction of actin ﬁlament barriers. The NK1R does not follow
this behavior. In the present case, the type I mobility receptor population did not increase after
actin-ﬁber or microtubule depolymerization, strongly suggesting a lack of direct interaction
of type I NK1Rs with the cytoskeleton. The relative low mobility of type I receptors could be
explained by the high propensity of NK1R to form diffusing membrane domains a few tens of
nanometers in size with high receptor density [196].
A high fraction of the NK1Rs exhibited a strictly restrained mobility and was therefore classiﬁed
as type II. Indeed more than one third of the receptors in the basal state were found to be
conﬁned in submicrometer-sized domains. The low interchange rate between receptors of
type II and other mobility regimes indicated that this restricted diffusion is not a consequence
of the fast transient recruitment described in the picket-fence model of the plasma membrane
[27], but is more likely due to the existence of very stable membrane structures in which
the NK1R is integrated. The low diffusion coefﬁcients measured for type II receptors did
not depend on intact actin ﬁlaments or microtubule structures, as no differences have been
observed in type II diffusion features upon treatment of cells with cytochalasin B or nocodazole.
The low D1−10 values observed are very likely due to molecular crowding related to membrane
regions of high protein-content. The high frequency of our measurements (30 Hz), combined
with the very high accuracy generated by the use of QDots to localize individual receptors
permitted us to exclude effects of domain size on the apparent diffusion coefﬁcients observed
elsewhere for other GPCRs with less photostable ﬂuorophores [205, 210]. A small part of
the receptors in the basal state remained immobile; this population probably stems from
constitutively internalized receptors. Although our results do not yield any indication of
direct or mediated interactions by a simple protein assembly of the NK1R with the cell’s
cytoskeleton, the NK1R is nevertheless tightly related to its surrounding. Indeed disruption
of the cytoskeleton had an indirect inﬂuence on the mobility pattern of the receptor through
structural modiﬁcations of the membrane.
Depolymerization of actin ﬁlaments is known to stimulate cell blebbing [211, 212]. Under
certain conditions, these blebs can be released as native microvesicles containing functional
NK1R [213]. The high fraction of type III receptors after cytochalasin B treatment is related to
membrane blebbing. The protein content of native vesicles is different from that of the cell’s
plasma membrane; in particular they lack cytoskeletal structure [214]. This explains the high
D1−10 observed for this population. Furthermore, the sub-micrometer size of the conﬁnement
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region is in total agreement with the results obtained elsewhere [212, 213].
SP is a potent natural agonist of the NK1R. It triggers multiple signaling pathways and re-
ceptor recycling. After activation, the NK1R is recycled via two distinct pathways: In a fast
process, receptors are recruited in plasma membrane domains or in early endosomes in close
proximity to the plasma membrane [61, 186]; in a slow process, the receptors are transported
to low pH perinuclear late endosomes [215, 216]. Both pathways are initiated by receptor
phosphorylation and subsequent arrestin binding. Our SPT results in presence of SP, show a
substantial decrease of NK1R mobility, consistent with an increased recruitment of the recep-
tors in structures related to the recycling pathways. This effect correlates with a decrease of the
overall diffusion coefﬁcient, mainly due to an increase of conﬁnement as seen by an important
shift from type I to type II receptors on the mobility patterns. Interestingly, only 30% of the
receptors undergo a change of mobility after activation. It has been shown elsewhere that
other cargo proteins associate transiently with CCPs during their formation and can dissociate
before pit termination or internalization; the dwell times of this process display a very broad
distribution from the second to hundred-second regime [217]. Taking this mechanism into
consideration, our results can be explained by an increase of the receptor afﬁnity for CCPs
after agonist binding, thus increasing the dwell time and favoring the internalization against
release of the receptor in the plasma membrane.
It is remarkable that this immobilization effect associated with receptor recruitment in CME
pathway depends on agonist concentration. The dose response curve resulting of the measure-
ment of the average Hurst parameter with increasing SP concentrations shows an EC50 value
of about 100 pM, which is comparable to the EC50 of the intracellular Ca2+ response indicating
that the ligand coordinated receptor immobilization might regulate the intracellular response.
The NK1R mobility change induced by the presence of low concentrations of agonist in the
environment would quickly regulate the cell response and therefore limit the intracellular
Ca2+ release in case of long-term agonist exposition.
An unexpected important result is that the decrease of CME functionality induced by the
clathrin-/dynamin-inhibitors Pitstop 2, Dyngo-4a, or Dynasore leads to a substantial increase
of type II receptors conﬁned in submicrometer membrane domains. Besides inhibition of
endocytosis, these molecules induce an accumulation of clathrin at the plasma membrane,
forming long-lived clathrin structures [218], including membrane-attached vesicles [219].
Clathrin can also exist in large patches on the plasma membrane without forming functional
pits or invagination [220, 221, 222]. The correlated decrease of both the diffusion coefﬁcient
and the Hurst parameter after inhibition of clathrin or dynamin indicates a stable interaction
of NK1R with these clathrin-related structures. Importantly, this is observed with all three
CME inhibitors indicating a speciﬁc clathrin effect. It is thus possible to exclude domain
recruitment due to clathrin-independent membrane processes, which could be affected by
dynamin inhibitors [223]. Receptors are accumulating in a pre-internalized state, that is either
in clathrin lattices, pre-pits [224], coated pits [225, 226], or in superﬁcial early endosomes
[185]. The fast accumulation of NK1R after CME inhibition strongly suggests a high association
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rate with these structures. Further support for the speciﬁc interaction of clathrin with the
NK1R comes from the observation that the distinct membrane organization of the receptor is
strongly affected after clathrin depletion.
Interaction of NK1R with clathrin-dependent structures and immobilization of activated
receptors are sequential events. In the absence of CME inhibitors, a large fraction of the
receptors are localized in relatively stable domains in an intermediary mobility state between
freely diffusing and internalized receptors. CME-inhibitors promote this state by increasing
the clathrin content at the membrane. In this state, receptors are diffusing in domains with
lower diffusion coefﬁcients and lower Hurst parameters. After activation with SP, the Hurst
parameters remained unchanged, while the diffusion coefﬁcients further decreased. The
interactions involved in domain recruitment and in immobilization after activation are dis-
tinct. Non-activated receptors interact with clathrin-dependent structures, forming transient
membrane domains, whereas activated receptors bind speciﬁcally to CCP through β-arrestin
and AP2.
CME inhibitors also strongly impaired receptor-mediated intracellular calcium signaling. This
decrease of the NK1R canonical activity can arise from several, non-exclusive reasons: (i)
The agonist binding site is not accessible due to the shape of the invagination as depicted on
Figure 1, (ii) G-proteins cannot bind the intracellular region of the receptor due to the densely
packed clathrin structures [227], (iii) receptor signaling is impaired by molecular crowding
[228]. Interestingly, disruption of microtubules, known to inhibit CME [229], does not alter
NK1R activity in our case.
The correlation between the clathrin-dependent change of receptor mobility and the decrease
of its activity, combined with the presence of a high fraction of type II receptors before acti-
vation, implies a clathrin-based mechanism for regulation of NK1R activity. Thereby, type II
receptors could act as a non-activated receptor reservoir directly and quickly available at the
cell membrane. This reservoir would have major implications in cell response to an agonist.
In particular, it would allow responding to successive or long-term agonist exposures. Indeed,
for a short exposition time to an agonist, only a fraction of the receptors must respond. A
gradual release of receptors from an inactive membrane reservoir could increase the response
in case of prolonged agonist exposition. Furthermore, such a mechanism would allow mul-
tiple intracellular Ca2+ responses to sequential agonist waves, without the need of newly
membrane-inserted receptors. This model is also compatible with the fast resensitization
observed elsewhere [186], albeit without the need of preliminary activation of NK1R.
Cholesterol removal with mβCD affects NK1R mobility and activity in a similar manner as
CME inhibition. Indeed, cholesterol depletion provokes a substantial decrease of the overall
diffusion of the receptor and practically abolished the intracellular Ca2+ response. Thus,
cholesterol, like clathrin, plays a major role on receptor mobility and is of critical importance
for its activity, corroborating the close link between mobility and activity.
The fast diffusing type III receptor population conﬁned in circular domains, which appears 30
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minutes after NK1R activation with SP, results from the presence of receptors in membrane
blebs or microvesicles. Membrane blebs are balloon-like structures of the plasma membrane
in which the cytoskeleton elements are generally absent, leading to enhanced molecular
diffusion. Tank et al. found a considerable increase of the diffusion coefﬁcients for both
membrane proteins and lipids [230], comparable to those found in liposomes [10]. Besides
the canonical signaling pathway leading to Ca2+ release from the endoplasmic reticulum,
SP induces cell membrane blebbing through the Rho/ROCK pathway by contraction of the
actomyosin cell cortex [83].
Y-27632 is a highly speciﬁc and efﬁcient cell-permeable Rho-associated coiled-coil kinase
(ROCK) inhibitor, which prevents NK1R-induced blebbing without affecting the apoptotic
state of the cells [83]. The mobility pattern resulting from NK1R trajectories measured in cells
treated with this inhibitor and stimulated with SP is characterized by the absence of type III
receptors. It demonstrates that the type III receptor population is directly dependent on the
activation of the Rho/ROCK pathway and thus on the presence of membrane blebs. Membrane
blebbing and excretion of microparticles are often associated with apoptosis. However, in our
case it has been shown that membrane blebbing is induced by activation of the NK1R by SP
and is hence an apoptosis-independent phenomenon. This particular cellular mechanism
may be of great importance for intercellular communication [84].
2.6 Conclusion
In summary, single-particle tracking and multi-parameter analysis allowed us to describe in
detail the diffusional behavior of the NK1 receptor in the plasma membrane of living cells.
The bimodal distribution of freely diffusing and conﬁned receptors observed in the basal
state is strongly shifted towards restricted mobility by receptor activation, whereas a new
population of fast diffusing receptors in circular domains, corresponding to receptors in
membrane blebs, resulted 30 minutes after activation of the Rho/ROCK pathway. Blocking of
the CME pathway using different inhibitors leads to receptor conﬁnement, which is correlated
to a signiﬁcant decrease of the receptor canonical pathway activity. Our results point to the
central importance of clathrin, not only in receptor endocytosis and turnover but also in NK1R
membrane homeostasis and ﬁne regulation of its activity.
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3 A monovalent StrepTactin for cross-
linking-free labeling of membrane
receptors
3.1 Abstract
Speciﬁc, stoichiometric and long-lasting tagging of biologically relevant molecules with ﬂuo-
rescent labels is of critical importance for single-molecule microscopy. The biotin-streptavidin
couple is often used to label proteins in living cells. In some cases, however, it may be prone to
cross-linking artifacts interfering with biological functions. Here, we present a novel method to
label directly Strep-tagged or biotinylated membrane receptors with high afﬁnity and virtually
no risk of cross-linking. Monovalent StrepTactin (mST) is a combination of one StrepTactin
subunit with three inactive streptavidin subunits. Under strict stoichiometric control of the
two subunits prior to refolding, we obtained a good yield of pure mST. Fluorescent derivatives
of mST were used for live-cell imaging of plasma membrane receptors. Semiconductor quan-
tum dot-mST conjugates were particularly well suited for long-term tracking of biotinylated
receptors at the single-molecule level.
3.2 Introduction
Streptavidin (SA) is a ∼53 kDa homotetrameric protein isolated from the bacterium Strepto-
myces avidinii [231]. Due to its extraordinarily high afﬁnity for biotin, it is extensively used in
biotechnology and molecular research for detection, puriﬁcation, cross-linking and labeling
of biomolecules [232, 233, 234]. The dissociation constant (Kd ) of the biotin-SA system is on
the order of 10−15M [165], making it the strongest noncovalent biological interaction known.
SA-based applications often require the biotinylation of the targetmolecules. Biotinylation can
be performed through chemical means or using enzymatic methods [235]. Although chemical
biotinylation methods are technically straightforward and offer a greater ﬂexibility, their lack
of target selectivity prevents in particular their use for live cell imaging of membrane proteins.
In this case, enzymatic biotinylation, which allows to link biotin at a unique speciﬁc site in the
63
Chapter 3. Monovalent StrepTactin
Kd (mol/L) SA ST
Biotin 10−14 [165] < 10−13 [242]
StrepTag II 10−4 [243] 10−6 [244]
Table 3.1: Dissociation constants (Kd ).
protein of interest, is more appropriate. The most commonly used method links by genetic
engineering a small peptide tag (termed acceptor peptide) to the N- or C-terminus of the
protein of interest and to use a biotin ligase (BirA) that will catalyze the covalent attachment
of biotin to a speciﬁc lysine residue of the tag [236].
The fact that the tetrameric SA can bind up to four biotinylated ligands imposes, in some
cases, a severe limitation of the method. The multivalency can cause target aggregation, which
may inﬂuence the biomolecule function or dynamics. Many efforts have been undertaken to
engineer a monomeric streptavidin. Unfortunately the biotin-binding afﬁnity of such proteins
remained many orders of magnitude lower than that of wild-type streptavidin [237] [238].
Howarth et al. have developed a monovalent tetrameric streptavidin (mSA) in which only one
of the four binding sites is functional [239]. This engineered recombinant form of streptavidin
is not subject for cross-linking and its single biotin binding site has an afﬁnity and off rate
similar to the tetravalent version [239, 240].
Here we adapt the approach of Howarth et al. to StrepTactin (ST), a triple mutant of SA (Figure
3.1A-B). ST also binds biotin with femtomolar afﬁnity, but the main feature of this engineered
SA is its optimized binding site for the Strep-Tag II, a short peptide tag of only eight amino
acid residues (Figure 3.1C) which can be fused to any protein of interest [241]. The afﬁnity of
ST for the Strep-Tag II is almost 100 times stronger than that of SA (Table 3.1). Monovalent
StrepTactin (mST) may therefore be of particular interest for direct, cross-linking-free labeling
of membrane proteins. In the following we evaluate the ability of ﬂuorescent mST conjugates
for live-cell imaging and single-molecule tracking of membrane receptors.
3.3 Experimental procedures
3.3.1 mST expression and puriﬁcation
pET21a-streptavidin-dead and pET21a-streptavidin-alive plasmids were a gift from Alice
Ting (Addgene plasmids # 20859 and # 20860, respectively). pET21a-StrepTactin-alive was
generated by Menno Tol from pET21a-streptavidin-alive using site-directed mutagenesis. E.
Coli BL21(DE3) pLysS cells (Invitrogen) transformed with pET21a expression plasmid encoding
StrepTactin-alive subunit or streptavidin-dead subunit were induced at an OD600 of 0.6 with
0.5 mM isopropyl β-D-1-triogalactopyranoside (IPTG). After 16h incubation at 37°C, cells
were harvested by centrifugation (4,200g, 20 min, 4°C), resuspended in ice-cold wash buffer
(50 mM Tris-HCl, pH 8.0, 500 mM sucrose), centrifuged again (20,000g, 30 min, 4°C) and
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Figure 3.1: StrepTactin and Strep-Tag II. (A) Protein sequence alignment of ST, SA and SD.
Mutations between ST / SD and SA are highlighted in purple and yellow, respectively. 6xHis
puriﬁcation tag at the N-terminus of ST and SA is in light blue. (B) X-ray structure of ST. The
four monomers are represented in different colors. Taken from [245]. (C) Chemical structure
of Strep-Tag II (WSHPQFEK).
resuspended in ice-cold lysis buffer 50 mM Tris-HCl pH 8.0, 1 mM EDTA). Cells were broken by
sonication and the crude cell extract was centrifuged (20,000g, 30 min, 4°C). The supernatant
was discarded whereas the inclusion body-rich pellet was washed three times in ice-cold
lysis buffer. Following the last centrifugation (200,000g, 30 min, 4°C) step, inclusion bodies
were solubilized in guanidinium hydrochloride (GuHCl) (6 M, pH 1.5). Solubilized samples
were homogenized and incubated at 50°C for 10 min. Insoluble material was removed by
centrifugation (20,000g, 10 min, 4°C) whereas the supernatant was dialyzed twice against
GuHCl in order to remove trace of biotin. The unfolded alive and dead subunits were mixed
in a 1:9 ratio, after having previously determined their relative concentration from OD280
values. mST was generated by dilution of the mixture into Dulbecco’s phosphate-buffered
saline (DPBS) (Invitrogen) under vigorous agitation. After ultracentrifugation (20,000g, 30
min, 4°C) and ﬁltration at 0.22 μm to remove aggregates, the protein was loaded onto a
Ni-NTA afﬁnity column (GE Healthcare) in presence of 30 mM imidazole to prevent non-
speciﬁc binding. His-tagged proteins were allowed to bind to the column using a continuous
ﬂow of 2 ml/min and with at least two successive passages. Elution was performed using
a linear imidazole gradient to a ﬁnal value of 500 mM. Puriﬁed proteins were concentrated
using 30 kDa molecular mass cut-off (MWCO) concentrators (Millipore) to a ﬁnal volume of
∼1ml. The puriﬁed proteins were analyzed by sodium dodecyl sulphate-polyacrylamide gel
electrophoresis (SDS-PAGE). In order to remove imidazole, the protein solution was passed
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through a NAP-10 column (GE Healthcare), which has been equilibrated with DPBS previously,
and elution was performed using with the same buffer. The concentration of proteins was
determined by measuring A280 with a Nanodrop 2000 (Thermo Scientiﬁc) assuming 1 Abs
= 1 mg/ml. Finally the concentrated sample was supplemented with 1 mM EDTA and 30%
glycerol (for cryopreservation), aliquoted, ﬂash frozen in liquid nitrogen, and stored at -80°C.
Tetravalent StrepTactin was puriﬁed similarly, except that only alive submits were used for the
refolding step.
3.3.2 Conjugation of Atto635 to mST
mST was conjugated to Atto635 N-hydroxysuccinimide (NHS) ester ﬂuorochrome (Atto-Tec)
followingmanufacturer’s instructions. First, mST solutionwas passed through aNAP-5 column
(GE Healthcare) pre-equilibrated with DPBS (pH 7.4) to remove EDTA (that would react
with NHS-ester). Eluted mST was then concentrated to 0.5 mg/ml with a 10 kDa MWCO
concentrator (Millipore). Conjugation reaction was initiated by mixing 20 μg of the protein
with a 10-fold molar excess of Atto635-NHS ester. The reaction was allowed to proceed for 40
min at room temperature on a rotating wheel. Puriﬁcation was performed by size-exclusion
chromatography using a NAP-5 column equilibrated with DPBS. After concentration to 0.2
mg/ml, 0.1% of BSA (Sigma-Aldrich) was added and mST-Atto635 was aliquoted and stored
frozen at -20°C protected from light.
3.3.3 Functionalization of QDots with mST
Amine-functionalized PEG-coated quantumdots (QDot 655 ITK amino (PEG), Invitrogen)were
used for the preparation of mST-QDots. QDots were activated with bifunctional crosslinker
BS3 (bis(sulfosuccinimidyl)suberate), followed by covalent conjugation with mST. QDots (200
μl, 0.2 nmol) were mixed with a 100-fold molar excess of BS3. The mixture was incubated
for 30 minutes at room temperature on a rotating wheel and then passed through a NAP-5
column pre-equilibrated with DPBS to remove excess of crosslinker. Eluted QDots were added
to a 10-fold molar excess of mST (mST:QD ratio of 10:1). After 4 hours incubation at room
temperature, the reaction was quenched by adding glycine to a ﬁnal concentration of 50 mM.
mST-QDots were puriﬁed using a 100 kDa MWCO ultraﬁltration device for at least six times
with borate buffer (50 mM, pH 8.3). mST-QDots were stored in borate buffer at 4°C.
3.3.4 Fluorescence Correlation Spectroscopy (FCS)
Biotin-Atto633 (M 962) conjugate and streptavidin (M 52,800) were obtained from Atto-Tec
and Sigma-Aldrich, respectively. All dilutions were made in DPBS buffer, pH 7.4. A ﬁxed
concentration of biotin-Atto633 (20 nM) was titrated with increasing concentrations of strepta-
vidin, StrepTactin or mST (0-50 nM). All samples were incubated 20 min at room temperature
in the dark before measurement.
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FCS measurements were performed using a LSM 510 Meta laser scanning microscope based
on an Axiovert 200M microscope stand equipped with a ConfoCor 3 FCS unit (Zeiss). This
allowed acquisition of photon-time traces and online correlation of the data. Biotin-Atto633
was excited at 633 nm by the built-in He-Ne laser (Lasos Lasertechnik). An acousto-optical
ﬁlter (AOTF) was used to adjust the exciting beam from the microscope objective (40x C-
Apochromat, NA 1.2, water immersion, Zeiss) in order to minimize photobleaching and
photophysical effects. The ﬂuorescence signal was collected through a LP650 emission ﬁlter.
Determination of the lateral beam waist radius ωxy of the laser was performed by measur-
ing the translational diffusion time constant τd of Alexa Fluor 647 (Invitrogen) with known
diffusion coefﬁcient (D = 3.3·10−6 cm2s−1) [246] according to equation 3.1.
ωxy = (4Dτd )1/2 (3.1)
A droplet (30-50 μl) of the sample solution was put on a coverslip mounted on the top of the
objective just before the start of the measurement which occurred 200 μm above the glass
surface. Fluorescence intensity time traces and correlation curves were recorded for ten times
10 s.
The correlation curves obtained from the FCSmeasurementswere ﬁttedwith a three-dimensional
diffusionmodel ofmultiple species using aMarquardt algorithmwith IGORPro (WaveMetrics),
according to equation 3.2:
G(τ)= 1+ 1
N
·
m∑
i=1
fi ·
(
1+ τ
τdi
)−1
·
(
1+ 1
S2τdi
)−1/2
(3.2)
where N is the total number of ﬂuorescent molecules in the observation volume, fi is the
fraction of species i from a total number of species m with diffusion time τdi , and S is the
structure parameter deﬁned by the ratio of the longitudinal to the radial dimension of the
laser focal spot.
To taken into account triple state, the second term may be multiplied by:
(
1+ Tr
1−Tr ·e
− τ
τTr
)
(3.3)
where Tr is the triplet amplitude and τTr the triplet lifetime.
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Finally the molecular mass M of the diffusing species can be estimated with equation 3.4:
τd =
3πω2xyη
2kT
(M)1/3 (3.4)
where η the viscosity of the sample, k the Boltzmann’s constant and T the temperature.
3.3.5 Surface Plasmon Resonance (SPR)
SPR measurements were carried out using a Biacore 3000 instrument (GE Healthcare). Protein
immobilization was performed in DPBS buffer at a ﬂow rate of 5 μl·min−1. Binding experi-
ments were performed in buffer containing 10 mM HEPES, pH 7.4, 150 mM NaCl, 0.02% C12E9
at a ﬂow rate of 10 μl·min−1. mST was covalently coupled to the surface of a sensor chip CM5
(GE Healthcare) using standard amine coupling procedure (EDC/NHS coupling). Strep-tagged
5-HT3R (100 nM) [247] was injected on the mST-functionalized surface of the sensor chip.
BiaEvaluation 4.1(GE Healthcare) and IGOR Pro softwares were used for data processing.
3.3.6 Cell culture
HEK293 cells stable cell lines were maintained at 37°C under a humidiﬁed 5% CO2 atmosphere
in tissue culture-treated ﬂasks (TPP) containing DMEM:F12 medium with GlutaMAX (Invitro-
gen) and 10% NBCS (Invitrogen). ACP-NK1R stable cell line [196] were grown in presence of
200 μg/ml of hygromycin B (Roche). Strep4-5-HT3R tetracycline-inducible cell line [247] was
grown in presence of 200 μg/ml hygromycin B and 10 μg/ml blasticidin (Invitrogen). When
cells reached 80-100% conﬂuency they were trypsinized, and re-seeded by 50-fold dilution into
fresh medium. For confocal microscopy and single-particle tracking experiments cells were
grown in DMEM:F12 medium with 10% NBCS but without antibiotics on 8-well chambered
glass slides (Nunc) for 24-48h.
3.3.7 Labeling of Strep-tagged receptors
Strep-tagged 5-HT3R was expressed either transiently or stably in HEK293 cells. Transient
transfection with pcDNA5/TO-Strep4-5-HT3R vector [247] was performed using Lipofectamine
2000 (Invitrogen) following the manufacturer’s instructions. Expression of Strep-tagged 5-
HT3R from the stable cell line [247] was induced with tetracycline (2 mg/ml) for 48h. Prior to
labeling, cells were washed once with DPBS containing 1% BSA. Cells were then incubated
with either 100 nM mST-Atto635 (confocal imaging), 10 nM mST-QDots (confocal imaging) or
100 pM mST-QDots (SPT) for 10 minutes at room temperature. Cells were washed three times
with colorless DMEM (Invitrogen) containing 1% BSA prior to measurements.
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3.3.8 Labeling of biotinylated receptors
HEK293 cells stably expressing ACP-NK1R [196] were labeled with CoA-biotin as described
previously (chapter 2, p. 43). Cells were then washed three times with DPBS 1% BSA prior
to incubation with 100 pM of mST-QDots for 10 minutes at room temperature. Cells were
washed three times with colorless DMEM 1% BSA prior to measurements.
3.3.9 Microscopy
Confocalmicroscopy Laser-scanning confocalmicrographswere recorded by using a LSM510
confocal microscope (Zeiss). Atto635 was excited at 633 nm by the built-in HE-Ne laser fo-
cused by a NA 1.2 63x water-immersion objective (Zeiss). QDots 655 were excited at 488 nm by
the built-in Ar-ion laser. Fluorescence was detected using photomultiplier tubes (PMT). The
imaging parameters were kept constant whenever intensity of ﬂuorescence was compared.
Single-Particle Tracking (SPT) 8-well plates were mounted on a modiﬁed epi-ﬂuorescence
wide-ﬁeld microscope (Axiovert 200, Zeiss). mST-QDots were excited at 488 nm (Obis diode
laser, Coherent Inc.). A circularly polarized laser beam was directed by a Q645LP dichroic
mirror (ChromaCorp.) into themicroscope objective (C-Apochromat 63xWCorr, 1.2NA, Zeiss)
to illuminate a 15-μm diameter region of the sample. Fluorescence emision was collected
by the same objective, passed through a HQ710/100 ﬁlter (Chroma Corp.), a 1.5x Optovar
(Zeiss), and imaged on a intensiﬁed charge-coupled device (CCD) camera (Ixon 887BV, Andor
Technology). Single-molecule images were recorded at a frequency of 30 Hz with excitation
intensities of 0.1 kW/cm2 during 33 s (i.e. 1000 frames). Measurements were taken at the
apical membrane of the cells.
SPT data evaluation Single-molecule trajectories were reconstructed from the positions
of the ﬂuorescent spots over time using a home-written software in IGOR Pro as described
previously (chapter 2, p. 44). Trajectories were segmented using a sliding window of 100
frames. Initial diffusion coefﬁcient (D1−10) and Hurst parameter (SMSS) were calculated for
each individual trajectory from the segments constituting the trajectory (average). Boxplots
were computed using R (R Foundation for Statistical Computing).
3.4 Results and discussion
3.4.1 Production of monovalent StrepTactin
Our goal was to produce a StrepTactin tetramer with only one functional binding site. To
achieve this we were inspired by the work of Mark Howarth and Alice Ting who developed an
elegant strategy to generate a monovalent streptavidin composed of three “dead” subunits
which have negligible biotin binding, and one “alive” subunit which is fully functional [239].
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The dead subunits were from a triple mutant (N11A, S15D, S33A) of streptavidin, whereas the
alive subunit was a wild-type streptavidin subunit fused with a 6xHis-tag at the C-terminus
[239]. In our case the alive subunit was replaced by a StrepTactin subunit (E32V, S33T, V35R).
The procedure used for generating monovalent StrepTactin is illustrated in Figure 3.2. The two
subunits, which were expressed separately in E. Coli, resulted in the formation of inclusion
bodies. After extraction and dissolution of the inclusion bodies in guanidinium hydrochloride,
the two unfolded subunits were mixed with an alive:dead ratio of 1:9 and then refolded by
dilution into DPBS buffer. By using a large excess of dead subunits compared to alive subunits,
we maximized the formation of mST while minimizing the formation of higher oligomeric
forms of ST. It is important to notice that because the dead subunit does not have a 6xHis-tag,
the homotetramer composed of dead subunits, which is the other majority species formed
during the refolding step is not puriﬁed.
Figure 3.2: Generation of mST. Streptavidin-dead (SD) and StrepTactin-alive (ST) were ex-
pressed separately in E. coli. Inclusion bodies were extracted and solubilized in 6 M GuHCl
(pH 1.5). To generate mST, SD and ST subunits were combined in a 9:1 ratio and refolded by
rapid dilution in DPBS. This refolding generated a mixture of mST and SD tetramers. mST,
which has a His-tagged subunit, was puriﬁed by Ni-NTA afﬁnity chromatography.
3.4.2 Veriﬁcation of tetramer subunit composition
In order to check the tetramer composition, we broke it into monomers by boiling the sample
before loading on SDS-PAGE (Figure 3.3). The two distinct bands just below 15 kDa correspond
to the dead and alive subunits (Figure 3.3A, 2nd lane). The alive submit (upper band) has a
higher mass due to the presence of the 6xHis-tag. Under similar conditions, homotetrameric
StrepTactin resulted in a single band (Figure 3.3B, 2nd lane). These results are in agreement
with the subunit composition of mST.
3.4.3 Binding to biotin
To assess the binding of biotin to mST, ﬂuorescence correlation spectroscopy (FCS) was used.
FCS is a powerful single-molecule detection technique that exploits temporal ﬂuorescence
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Figure 3.3: Coomassie blue stained SDS-PAGE of StrepTactin tetramers under nondenatur-
ing conditions (lane 1) or denaturing conditions (95°C, 5 min) to break the tetramers into
monomers (lane 2). A. Monovalent StrepTactin (mST). B. Tetravalent StrepTactin.
intensity ﬂuctuations produced by a small number of ﬂuorescently labeled molecules diffusing
into and out of the confocal detection volume of about 10−15 L (Figure 3.4A-B) to characterize
diffusional mobility, concentration, and brightness of the labeled molecules [248].
The time a molecule spends in the detection volume (diffusion time, τd ) is directly related
to its molecular mass M according to equation 3.4. An increase in diffusion time shifts the
autocorrelation curve also to longer correlation times. Thus freely diffusing biotin can be
easily discriminated from bound biotin by measuring the respective diffusion time. The auto-
correlation data and ﬁtting curves for biotin-Atto633 in absence or in presence of an excess of
mST are shown in Figure 3.4C. Using a three-dimensional one-component ﬁt we obtained
diffusion times of τd=58 and τd= 227 μs for free biotin and bound biotin, respectively. These
values correspond to species having a molecular mass of about 1 and 60 kDa, which is in good
agreement with the theoretical values of M of biotin-atto633 and mST. This result indicates
that our mST construct is functional with respect to biotin binding.
We attempted to evaluate the valency of our mST construct by a FCS titration approach in
which a ﬁxed concentration of biotin-Atto633 (20 nM) was titrated with increasing concen-
trations of SA, ST or mST (0-50 nM). The resulting autocorrelation curves are displayed in
Figure 3.4D-F. Due to the numerous parameters that can inﬂuence the FCS measurements of
the present experiment, such as the brightness of the diffusing species (multiple species of
different brightness for SA and ST, quenching phenomenon), the accuracy of the concentra-
tion of the different samples, and the potential presence of non-labeled biotins or free dyes, a
quantitative analysis turned out to be difﬁcult. From a qualitative perspective however, the
differences between the three tetramers are obvious. Titrations with SA (Figure 3.4D) and ST
(Figure 3.4E), which have both four biotin binding sites, display almost identical behavior with
a sudden shift of the correlation curves to longer times at a given concentration. In the case
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of mST (Figure 3.4F), this shift is more gradual. This ﬁnding supports the fact that our mST
construct has a unique biotin binding site.
Figure 3.4: FCS to probe interaction of streptavidin (SA), StrepTactin (ST) and monovalent
StrepTactin (mST) with biotin. (A) Scheme of FCS. A tightly focused laser beam (red ellipse)
excites ﬂuorophores linked to biotin (red ﬁlled circles). (B) Excited biotin leads to ﬂuctuations
in the ﬂuorescence time trace. (C) Autocorrelation functions (ACFs) for 20 nM of biotin-
Atto633 in absence or presence of 70 nM of mST. The ACFs were ﬁtted with a 3D 1-component
diffusion model (blue dashed lines). (D) ACFs for 20 nM biotin-Atto633 titrated with SA from 0
to 50 nM. (E)-(F) Same as (D), but with ST and mST, respectively.
3.4.4 Binding to Strep-Tag II
mST binding to Strep-tagged proteins was investigated by surface plasmon resonance (SPR)
spectroscopy [249]. This label-free technique exploits the phenomenon of SPR to monitor
bimolecular interactions in real-time. Its principle is schematically represented in Figure 3.5.
Monochromatic p-polarized light is applied to the surface of a gold-coated sensor chip. The
intensity of the reﬂected light drops at certain incident angle (SPR angle) due to plasmon
resonance. The SPR angle is very sensitive to the refractive index of the solution near the
surface of the sensor. Interaction of any molecules with the surface induces an increase of
the refractive index, which causes a shift of the SPR angle. Injection of solubilized, puriﬁed
Strep-tagged 5-HT3Rs (kindly provided by Cédric Deluz [247]) on a mST-functionalized sensor
chip led to a strong increase of the SPR signal (Figure 3.5 - right), demonstrating the binding
functionality of mST toward Strep-Tag II.
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Figure 3.5: Biacore’s SPR biosensor to measure binding of mST to StrepTagII-5-HT3R. Gold
surface covered with a layer of carboxymethylated dextran (not shown) was functionalized
with mST via EDC/NHS mediated amino coupling procedure. Then solubilized Strep-tagged
5-HT3R was injected on the surface. The binding of the latter to mST resulted to an increase of
the SPR signal measured in resonance units (RU). The recorded sensogram is shown on the
right.
3.4.5 Organic dye-mST conjugate for labeling membrane receptors in living cells
In order to test the binding functionality of our mST construct on living cells, mST was
conjugated to the organic dye Atto635 via NHS ester reaction to primary amines (Figure
3.6A). mST-Atto635 was characterized using FCS. The molecular brightness (i.e. the mean
ﬂuorescence count rate per molecule or CPM) of mST-Atto635 was about 1.5 times that of
the free dye, indicating that we are close to a 1:1 ratio (Figure 3.6B). Fluorescence confocal
microscopy showed that mST-Atto635 is able to speciﬁcally bind Strep-tagged receptors in the
plasma membrane of living cells (Figure 3.6C).
3.4.6 mST-QDot conjugate for tracking individual receptors in living cells
Fluorescent semiconductor QDots have recently emerged as a powerful tool to probe bi-
ological processes at the single-molecule level [129]. The major advantage of QDots over
ﬂuorescent dyes and proteins is their extremely high brightness and photo-stability, thus
allowing high resolution and long term tracking of individual molecules [250]. Here we func-
tionalized CdSe:ZnS QDots with mST and evaluated their potential for labeling and tracking
cell membrane receptors.
QDots were coupled to mST via an amine-to-amine crosslinker (Figure 3.7A). Fluorescence
confocal microscopy (Figure 3.7B) showed that 10 nM of mST-QDots stained the membranes
of cells expressing Strep-tagged 5-HT3R but not those not expressing the receptor. mST-QDots
are therefore suitable for ensemble measurements.
Lowering the concentration of mST-QDots in order to label only a few receptors per cells was
not successful. Despite testing numerous labeling conditions by varying concentration and
incubation time, the difference between cells expressing and not expressing Strep-tagged
5-HT3R was insigniﬁcant (data not shown). This suggests that afﬁnity of mST towards the
StrepTag is not strong enough to reliably track single molecules in living cells.
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Figure 3.6: mST-organic dye conjugation and characterization. (A) Conjugation reaction
between an organic dye, Atto635-NHS ester, and an amino group of mST yielding a stable
carboxamide-linked conjugate. (B) ACFs and molecular brightness (CPM) for mST-Atto635
conjugate and free dye. (C) Confocal ﬂuorescence images showing living HEK293 cells sta-
bly (top) or transiently (bottom) expressing Strep-tagged 5-HT3R labeled with 100 nM mST-
Atto635.
To track individual membrane receptors through mST, a biotin molecule had to be attached to
the receptors. Cells stably expressing ACP-NK1R, labeled with CoA-biotin, and incubated with
100 pM of mST-QDots, resulted in the presence of a few tens of diffusing QDots (Figure 3.7
C, left), whereas QDots were absent from the plasma membrane of cells not expressing ACP-
NK1R, but still labeled with CoA-biotin (Figure 3.7 C, right). Individual receptor trajectories
from a single cell and their correspondingMSD vs tl ag plots are shown in Figure 3.7D. Diffusion
of the NK1R is very heterogeneous and transitions between modes of motion during the course
of some trajectories were observed (Figure 3.8).
3.4.7 SA-QDots vs. mST-QDots to track membrane receptor dynamics
A major drawback of the widely used streptavidin-biotin couple is the potential risk of cross-
linking (i.e. one Qdot binds to several receptors). Receptor cross-linking may strongly affect
the diffusion and internalization of membrane receptors or even inﬂuence their signaling
function [121]. In this respect, we were concerned that the commercial SA-QDots previously
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Figure 3.7: mST-QDot conjugation, characterization and tracking. (A) Functionalization of
QDot with mST using bis[sulfosuccinimidyl] suberate (BS3), an homo-bifunctional amine-to-
amine crosslinker. (B) Confocal ﬂuorescence images (top) and the corresponding transmission
images (bottom) of livingHEK293 cells stably expressing (left) or not expressing (right, negative
control) Strep-tagged 5-HT3R, and labeled with mST-QDots (10 nM). (C) (Left) Wide-ﬁeld
ﬂuorescence image of living HEK293 cells, stabling expressing ACP-NK1R, labeled with CoA-
biotin and incubated with mST-QDots (100 pM); (right) negative control: HEK293 cells not
expressing ACP-NK1R, labeled with CoA-biotin and incubated with mST-QDots (100 pM). (D)
Diffusion trajectories of individual biotinylated NK1Rs labeled with mST-QDot in the upper
cell membrane of single cell and the corresponding MSD versus tl ag plots. The averaged
diffusion coefﬁcients range from 0.003 to 0.02 μm2/s.
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Figure 3.8: Heterogenous diffusion within a single receptor trajectory. 1000-frames trajec-
tory (33 Hz) of a single biotinylated NK1R labeled with a single mST-QDot. At the beginning the
receptor diffusion is conﬁned, then it becomes Brownian, before it becomes again conﬁned.
used to track biotinylated NK1Rs (chapter 2, p. 39) could induce cross-linking, thus altering
the mobility of the receptors. We compared the initial diffusion coefﬁcients (D1−10) and the
Hurst parameters (SMSS) obtained with SA-QDots and mST-QDots and found no signiﬁcative
difference (Figure 3.9). These results suggest that, in the present case, NK1R cross-linking by
SA-QDots is negligible. However this does not mean that SA-QDots cannot cause receptor
cross-linking. Parameters such as expression level and oligomerization state of the receptor
have to be taken into account. In the present case, the fact that the NK1R is monomeric [196]
and expressed at moderate level (∼ 25,000 receptors per cell [196]) are conditions that tend to
minimize the risk of cross-linking.
3.5 Conclusion
mST allows direct, one step labeling of Strep-tagged membrane proteins, without risk of
cross-linking. The use of the genetically-encoded Strep-Tag II allows to bypass the enzymatic
biotinylation step, providing a certain superiority over the streptavidin-biotin system in terms
of simplicity, rapidity and speciﬁcity. However for single molecule applications, the micro-
molar afﬁnity of StrepTactin for Strep-Tag II cannot compete with its femtomolar afﬁnity for
biotin, and constitutes the major limitation of system.
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Figure 3.9: Comparison of SA-QDots and mST-QDots diffusion. (A) Boxplots of the diffusion
coefﬁcient D1−10 of biotinylated NK1Rs labeled with SA-QDots (right, n= 53) or mST-QDots
(left, n= 95). (B) Boxplots of the Hurst parameter SMSS for the same trajectories than in A.
The median is drawn as a horizontal line. Notches indicate the 95% conﬁdence interval of
the median. Boxes represent the interquartile ranges of the distribution. P-values are from a
Wilcoxon rank sum test, testing the null hypothesis H0: SA-QDots population is not different
from mST-QDots population.
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4 Tracking 5-HT3 receptor dynamics
using a ﬂuorescent nanobody
4.1 Abstract
Diffusion of cell surface receptors is of critical importance for correct localization and reg-
ulation of receptor activity. In this context, single-molecule ﬂuorescence techniques that
allow to follow the motion of individual receptors are particularly attractive as they reveal the
full distribution of molecule behaviors and circumvent the averaging inherent in traditional
ensemble measurements. Here, we used a ﬂuorescent nanobody (VHH15-CF640R) to track the
5-HT3 receptor in the plasma membrane of living neuronal cells. This novel high-afﬁnity label
which is small, monovalent and highly photostable enabled long-term tracking of individual
5-HT3Rs and revealed a surprising and intriguing diffusional behavior of some receptors.
4.2 Introduction
Single-molecule tracking (SMT) ﬂuorescence microscopy offers a unique way to directly
observe individual molecules at work in living cells. By overcoming averaging intrinsic to
ensemble measurements, SMT yields critical information for elucidating the molecular basis
of dynamic events taking place in a complex and heterogenous environment such the plasma
membrane. SMT not only probes the dynamic behavior of the investigated molecules but also
provides fundamental insights into the organization of the surrounding membrane and the
molecular interactions between membrane components [251, 170].
In order to detect single biomolecules optically, they have to be labeled speciﬁcally with an
optical probe. For ﬂuorescence microscopy the ideal probe should (i) bind the target molecule
with high afﬁnity and speciﬁcity, (ii) be highly photostable (for long-term observations), (iii) be
extremely bright (for precise localization), (iv) be monovalent (to avoid cross-linking), (v) not
perturb the dynamics and functions of the target molecule, and (vi) be as small as possible (to
access narrow spaces). Although this perfect probe is still a biophysicist’s dream, the past few
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years have seen the semiconductor quantum dots become ever smaller [252] and the organic
dyes ever more stable [146], making these two ﬂuorophores still more attractive. Here we used
CF640R, a novel rhodamine-based far-red dye. Its excellent ﬂuorescence quantum yield and
exceptional photostability, combined with its remarkable low non-speciﬁc binding to cells,
make it a prime candidate for single-molecule imaging [253, 254]. The ligand used to attach
the ﬂuorophore to the target biomolecule plays also a key role in this quest of the perfect
probe. Commonly used streptavidin and conventional antibodies are large and multivalent,
abolishing the beneﬁts of the newly developed small photostable ﬂuorophores. Small probes
are not only less likely to interfere with the dynamics and function of the target molecule, but
also minimize the linkage error caused by the displacement of the ﬂuorophore. This last point
is of particular importance for super-resolution localization microscopy [255].
Here we took advantage of the recently developed single-domain antibodies. Camelids such as
llamas produce antibodies which naturally lack light chains. The antigen binding fragment of
these heavy-chain-only antibodies, termed nanobody or VHH, consists of a single monomeric
variable domain which can be easily expressed recombinantly [256]. The small size, monova-
lency, robustness, and ease of production of nanobodies have made them a promising and
versatile tool for molecular imaging and therapeutic purposes [257, 258, 259]. In structural
biology, the use of nanobdies as crystallization chaperones led to the elucidation of the X-ray
structure of major membrane receptors such as the β2 adrenergic-Gs protein complex [260]
or the mouse 5-HT3R [96].
For single-molecule tracking experiments, the employment of nanobody-based probes is still
in its infancy. The few single-molecule studies dealing with nanobodies have mostly used
nanobodies targeting ﬂuorescent proteins fused to the protein of interest [255, 261, 262, 263,
264].
In this paper, we designed VHH15-CF640R, a ﬂuorescent nanobody that binds directly, and
with high afﬁnity to the 5-hydroxytryptamine type 3 receptor (5-HT3R) [96]. This cationic
ligand-gated ion channel, belonging to the pentameric Cys-loop receptor superfamily [91],
is present in the central and peripheral nervous systems where it mediates and modulates
fast excitatory responses to serotonin (5-HT). It is the target of potent drugs used to treat and
prevent nausea and vomiting triggered by chemotherapy [265]; 5-HT3R antagonists may also
be used in personalized medicine for treating complex psychiatric disorders such as anxiety,
depression or psychosis [108].
Single-molecule investigations on the mobility of other members of the Cys-loop receptor
superfamily, such as the glycine [266], GABA [209] and AMPA [267] receptors have highlighted
the importance of the dynamic movements of these receptors in the regulation of synaptic
transmission [251, 268].
The diffusional behavior of the 5-HT3R has not been extensively studied and our understand-
ing of the principles underlying its organization in the cellular plasma membrane is extremely
limited. Herein, we demonstrate the potential of VHH15-CF640R for direct labeling and track-
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ing of individual native 5-HT3Rs and resolve the inﬂuence of the cytoskeleton on the complex
mobility pattern of this particular serotonin receptor.
4.3 Materials and methods
4.3.1 Materials
Materials for cell culture like DMEM:F-12 with GlutaMAX, newborn calf serum (NBCS), trypsin-
EDTA, Dulbecco’s PBS, and blasticidin were from Invitrogen. Hygromycin was from Roche.
Tetracycline and laminin (from mouse Engelbreth-Holm-Swarm sarcoma) were from Sigma-
Aldrich. Poly-D-lysine was from EMD Millipore. Complete neurobasal growth medium was
kindly provided by Lilian Glauser (Laboratory of Prof. Johannes Gräff, EPFL). VHH15 [96]
with a single C-terminal cysteine was a gift from Ghérici Hassaine (Theranyx, Marseille).
CF640R-maleimide, Tris(2-carboxyethyl)phosphine hydrochloride (TCEP·HCl), bovine serum
albumine (BSA), latrunculin A and nocodazole were purchased from Sigma-Aldrich.
4.3.2 Cell culture
T-REx-293 cell line stably expressing the mouse wild-type 5-HT3A receptor [247] and neu-
roblastoma x glioma hybrid NG108-15 cells (Sigma-Aldrich) were cultured at 37°C under a
humidiﬁed 5% CO2 atmosphere in tissue culture-treated ﬂasks (TPP) containing DMEM/F12
medium and 10% v/v NBCS. T-REx-293 stable cells were kept under selective pressure by the
presence of 100 μg/ml hygromycin and 5 μg/ml blasticidin. When cells reached 80-100%
conﬂuence they were detached from the surface by trypsinization or DPBS (without calcium
or magnesium), and reseeded by a 5-50 fold dilution into fresh medium. NG108-15 cells were
seeded 24-48 h before microscopy experiments in 8-well chambered glass slides (Nunc). T-TEx
stable cells were grown in absence of antibiotics on 8-well chambered glass slides and 5-HT3R
expression was induced by adding 5 μg/ml tetracycline 24 h after seeding and 48 h before
measuring.
Newborn mouse primary cortical neurons were obtained from Lillian Glauser. The cells were
grown in 8-well chambered glass slides pre-coated with mouse laminin (32 μg/ml) and poly-
D-lysine (200 μg/ml) in neurobasal medium supplemented with B27 (2% v/v), L-glutamine
(500 μM) and penicillin/streptomycin (100 U/ml). Experiments were performed on cultures
grown for ∼14 days.
4.3.3 Synthesis of VHH15-CF640R
VHH-15 (133 μg) containing a single C-terminal cysteine residue were reduced by incubation
with 100 mM TCEP in DPBS for 20 min at room temperature under argon. CF640R-maleimide
was added in 10-fold molar excess and incubated with rocking for 2 h at room temperature,
protected from light. Labeled nanobodies were separated from free CF640R-maleimide by gel
81
Chapter 4. Tracking 5-HT3 receptor dynamics using a ﬂuorescent nanobody
ﬁltration using a Sephadex G-25 column (GE-healthcare).
Figure 4.1: Reaction conjugation of VHH15 with CF640R-maleimide at cysteine residue.
4.3.4 5-HT3R labeling
Prior to labeling, cells were washed 1x with warm (34 °C) serum-free, phenol red-free DMEM
supplemented with 1% BSA. For confocal microscopy, cells were incubated with 200 nM
VHH15-CF640R for 45 min at 37°C. For SMT experiments, NG108-15 cells were incubated with
100 pM VHH15-CF640R for 30 min at 37°C. For T-REx stable cells and primary cortical neurons,
VHH15-CF640R concentrations of 10 pM and 200 nM were used, respectively. Imaging was
performed in serum-free, phenol red-free medium supplemented with 1% BSA.
4.3.5 Drug treatments
Latrunculin A andnocodazolewere dissolved inDMSO. The treatment of cells with cytoskeleton-
disrupting drugs was done by incubating the cells in serum-free, phenol red-free DMEM
supplemented with 1% BSA, and containing either 1 μM latrunculin A (0.01% DMSO) or 10
μM nocodazole (0.05% DMSO) at 37 °C. SMT measurements were performed 5 min or 10 min
after latrunculin A or nocodazole addition respectively, and carried out only during the ﬁrst 20
minutes after addition of the drug without washing.
4.3.6 Confocal microscopy
Confocal micrographs were taken using a LSM510 Meta laser scanning microscope (Zeiss)
equipped with a 63X/1.2NA water-immersion objective using the red HeNE laser (633 nm) and
appropriate excitation and emission ﬁlters. Fluorescence was detected using photomultiplier
tubes (PMT).
4.3.7 SMT experiments
Measurements were performed on the basal plasma membrane of the cell body using total
internal reﬂection ﬂuorescence (TIRF)microscopy. A schematic viewof the experimental setup
can be found in Appendix A (p. 96). The samples were mounted on an inverted ﬂuorescence
microscope (Nikon Eclipse Ti), equipped with a high numerical aperture oil objective (Apo
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TIRF 100x, NA 1.49, Nikon). A 640 nmObis diode laser (Coherent Inc.) was used in combination
with an AOTF (acousto-optical tunable ﬁlter) to illuminate the sample with 100 ms exposure
time and excitation intensity around 0.5 W/cm2. Movies of typically 500 frames were recorded
at 10 Hz on an EMCCD camera (Ixon 887BV, Andor Technology). The region-of-interest was
set to 128 x 128 pixels. The image pixel size was 160 nm.
4.3.8 Data analysis
SMT data analysis was performed using a home-written software in IGOR PRO (WaveMetrics),
as detailed elsewhere [269]. Brieﬂy, trajectories were reconstituted by linking ﬂuorescent
peaks in successive frames. Trajectories with a minimum of length of 200 frames were then
segmented using a sliding window of 100 frames. Each resulting segment was treated as
an individual trajectory from which the initial diffusion coefﬁcient (D1−10) and the Hurst
parameter (SMSS) were determined. D1−10 was evaluated from a linear ﬁt to the ﬁrst 10 time
intervals of a standard means square displacement (MSD) versus tl ag plot. SMSS , which
corresponds to the slope of the moment scaling spectrum (MSS) [157] is a reliable parameter
to identify the mode of motions; a SMSS value between and 0.5 indicates sub-diffusion (e.g.,
conﬁned diffusion) and a value between 0.5 and 1 characterizes super-diffusion (e.g., diffusion
resulting from active cellular transport processes); Brownian movements are represented
by SMSS values around 0.5. D1−10 and SMSS parameters were combined in a color-coded,
two-dimensional probability density plot (mobility pattern) using the functions kde2d() and
ﬁlled.contour() in R (R Foundation for Statistical Computing). Bandwidths of 0.4 on the x axis,
corresponding to log10(D1−10), and 0.11 on the y axis, corresponding to SMSS , were used. Box
plots showing the distribution of both parameters were computed using the averaged values
of the full-length trajectories (calculated from the segments constituting the trajectory).
4.4 Results
4.4.1 Direct labeling of the 5-HT3R using a ﬂuorescently labeled VHH
5-HT3Rs present in the plasma membrane of live cells were labeled with VHH15-CF640R, a
single-domain antibody (VHH) against the 5-HT3R [96] to which a small organic red ﬂuores-
cent dye (CF640R) has been chemically attached. The ability of VHH15-CF640R to speciﬁcally
bind to the 5-HT3R was assessed using confocal microscopy (Figure 4.2). TRex-HEK293 cells
stably expressing large amounts of recombinant 5-HT3R (1-2 million receptors per cell [247])
exhibited high levels of surface labeling (Figure 4.2B). NG108-15 cells, which endogenously
expressed modest levels of 5-HT3R displayed weaker and more punctuate staining at the
plasma membrane (Figure 4.2A). No labeling was observed at the membrane of HEK293 which
do not express the receptor (negative control, Figure 4.2C), thus demonstrating the probe’s
speciﬁcity.
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Figure 4.2: Confocal ﬂuorescence micrographs (upper panels) and white light transmission
images (lower panels) showing VHH15-CF640R staining of 5-HT3R in (A) NG108-15 cells, (B)
tretracycline-inducible TRex-HEK293 stable cell line expressing the mouse homopentameric
5-HT3A receptor, and (C) TRex-HEK293 parental cells (negative control, without washing).
Scale bars correspond to 20 μm.
4.4.2 VHH15-CF640: a perfect probe for tracking individual 5-HT3Rs
By using VHH15-CF640R concentrations in the picomolar range, about ten receptors per
cell were labeled. In addition to being highly speciﬁc, the binding of VHH15 to 5-HT3R is
quasi irreversible (koff = 4.7·10−6 s−1 [96], corresponding to t1/2≈41 h). This extreme afﬁnity,
combined with the high photostablity of CF640R, allowed us to monitor the lateral movements
of individual receptors for extended periods of time. The good quantum yield of CF640R, its
observation in the red spectral region where cellular autoﬂuorescence is signiﬁcantly reduced,
and the use TIRF microscopy enabled to obtain excellent signal-to-noise ratios (Figure 4.3A-B),
improving signiﬁcantly the tracking precision.
Our SMT experiments revealed an extraordinary diversity of complex trajectories (Figure 4.3C-
D), corroborating observations reported in a previous study [270]. Freely diffusing, conﬁned,
immobile and directed 5-HT3Rs were observed, but also receptors exhibiting transitions
between these modes of motions. This heterogeneity is reﬂected in the broad distribution of
initial diffusion coefﬁcients (D1−10), ranging from 0.001 to 0.5 μm2/s, and Hurst parameters
(SMSS), ranging from 0 to 0.65 (Figure 4.4).
4.4.3 Comparison of the lateral mobility of heterologously and endogenously ex-
pressed receptors
We compared the mobility of the 5-HT3R in NG108-15 neuroblastoma-glioma cells, which
endogenously expressed moderate levels of the receptor, to that in HEK293, which over-
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Figure 4.3: Imaging and tracking of individual 5-HT3Rs in living cells. (A) Typical image
of single VHH15-CF640R bound to 5-HT3R in the basal plasma membrane of NG108-15
cells as imaged with TIRF microscopy. (B) 3D plot of the intensities of the single molecules
imaged in A. (C) Trajectories of individual 5-HT3Rs diffusing in the basal plasma membrane
of NG108-15 cells (left) or TRex-HEK293 cells (right). The positions of the ﬂuorescent probes
were determined with sub-pixel accuracy using 2D Gaussian ﬁtting of the ﬂuorescent peaks.
Single-molecule trajectories were reconstructed by linking the positions over time in a series
of frames recorded at 10 Hz.
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expressed the receptor on the order of millions of receptors per cell [247]. The two resulting
mobility patterns display a similar overall shape but with a total redistribution of the mobile
and conﬁned fractions (Figure 4.4A-B). Receptors heterologously expressed in HEK293 cells
exhibit amuchmore restricted lateralmobility than those natively expressed inNG108-15 cells;
this is reﬂected by the signiﬁcantly lower diffusion coefﬁcients and lower Hurst parameters as
revealed by the associated box plots (Figure 4.4C-D). The reduced mobility is very likely due to
crowding effects related to high protein content in the membrane [271].
4.4.4 A particular diffusional behavior of 5-HT3R in NG108-15 cells
The diffusion of the 5-HT3R in NG108-15 showed numerous trajectories with a characteristic
elongated shape, as represented on Figure 4.5A. These trajectories are deﬁned by high diffusion
coefﬁcients (> 0.05 μm2/s) and by Hurst parameters ranging from 0.2 to 0.6 (Figure 4.5C).
Interestingly, receptors exhibiting such trajectories do not move only in one direction but
rather back-and-forth, presumably along a structure underlying the plasma membrane (Figure
4.5B). These trajectories are hence not directed as might be expected, but they are Brownian
(SMSS ≈ 0.5), directed (SMSS > 0.5) and conﬁned (SMSS < 0.5) at the same time: the receptor
exhibits a combination of Brownian diffusion and apparently directed movements, restricted
in elongated domains.
4.4.5 Effect of cytoskeleton-disrupting agents on receptor mobility
We investigated whether this diffusion in elongated domains was the result of transport events
along cytoskeletal components. We ﬁrst disrupted the microtubules with 10 μM nocodazole, a
microtubule-depolymerizing agent. This resulted in an increase of the fraction of immobile
receptors (D1−10 < 0.001 μm2/s, SMSS < 0.1), whereas the highly mobile fraction remained
unaffected (Figure 4.6B). A speciﬁc effect to nocodazole was the disappearance of the peak of
intermediate mobility (0.005<D1−10 < 0.01 μm2/s, 0.15 < SMSS < 0.35) which is present both in
non-treated cells and latrunculin A-treated cells.
We next probed the inﬂuence of the actin cytoskeleton on 5-HT3R diffusion by treating the
cells with 1 μM latrunculin A to disrupt the actin ﬁlaments. Surprisingly, this resulted in a
signiﬁcant decrease of the overall mobility of the receptor as reﬂected in the corresponding
mobility pattern (Figure 4.6C). This effect was correlated with a decrease of the median short
term diffusion coefﬁcient (Figure 4.6D) and an increase of the conﬁnement (lower SMSS values)
(Figure 4.6E). Importantly, the population of fast diffusing receptors (D1−10 > 0.05 μm2/s),
corresponding in particular to receptors diffusing in elongated domains was reduced (Figure
4.6C). As directed diffusion is characterized by SMSS values > 0.5, the proportion of directed
segments was reduced from 16% to 8% after latrunculin A treatment. Taken together these
results suggest that the actin cytoskeleton is involved in the particular diffusional behavior of
the 5-HT3R.
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Figure 4.4: Comparison of 5-HT3R mobility in high- and low-expressing cells. (A) Mobility
pattern of 5-HT3R in NG108-15 cells expressing low levels of the receptor (endogenous ex-
pression). (B) Mobility pattern of 5-HT3R in HEK293 stable cell line (SCL) expressing high
levels of the receptor. The color code scales with the indicated frequency (arbitrary units) of
states. (C) Box plot of the diffusion coefﬁcient D1−10 in NG108-15 (n=259) cells and in HEK293
SCL (n=133). (D) Box plot of the Hurst parameter SMSS for the same trajectories as in C. The
median is drawn as a horizontal line. Notches indicate the 95% conﬁdence interval of the
median. Boxes represent the interquartile ranges of the distribution. p-values were obtained
by a Wilcoxon ranking test on the distribution; ∗∗p-value <0.01, ∗∗∗p-value <0.001 with the
null hypothesis (H0) that population A is not different from population B.
87
Chapter 4. Tracking 5-HT3 receptor dynamics using a ﬂuorescent nanobody
Figure 4.5: Special diffusion of individual 5-HT3Rs. (A) Typical trajectories of 5-HT3Rs dif-
fusing in elongated domains at the basal plasma membrane of NG108-cells. (B) Trajectory
(framed in red in A) colored according to time, highlighting the back-and-forth movements of
the receptor. Start (t=0 s) and end (t=46 s) of the trajectory is indicated. (C) Mobility pattern of
an arbitrary selection of elongated trajectories (n=21). The color code scales with the indicated
frequency (arbitrary units) of states.
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Figure 4.6: Effect of cytoskeletal disruption on 5-HT3R mobility in NG108-15 cells. (A) Mo-
bility pattern of 5-HT3R in absence of cytoskeleton-disrupting drugs . (B) Mobility pattern in
the presence of 10 μM nocodazole. (C) Mobility pattern in the presence of 1 μM latrunculin
A. The color code scales with the indicated frequency (arbitrary units) of states. (D) Box plot
of the diffusion coefﬁcient D1−10 in absence of drugs (n=259), in the presence of nocodazole
(NOC) (n=105), and in the presence of latrunculin A (LAT A) (n=90). (E) Box plot of the Hurst
parameter SMSS for the same trajectories as in (E). The median is drawn as a horizontal line.
Notches indicate the 95% conﬁdence interval of the median. Boxes represent the interquartile
ranges of the distribution. p-values were obtained by a Wilcoxon ranking test on the distribu-
tion; ∗p-value <0.05, ∗∗p-value <0.01, ∗∗∗p-value <0.001 with the null hypothesis (H0) that
population A is not different from population B.
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SMT in primary neuronal cultures (preliminary results)
A few single-molecule trajectories were obtained on living primary mouse cortical neurons. A
selection of trajectories is presented in Figure 4.7.
Figure 4.7: Trajectories of individual 5-HT3Rs diffusing in the cell body membrane of living
neurons.
4.5 Discussion
Nanobodies constitute a remarkable new tool for direct labeling of membrane proteins in
vivo. Their small molecular size (∼ 2 x 4 nm) is far less likely to cause interferences with
the dynamics and functions of the target protein and allows them to access conﬁned and
crowded cellular regions. Moreover their monovalency prevents any risk of cross-linking,
unlike streptavidin and conventional antibodies. Combined with a small organic dye having a
good photostability, this makes a ﬂuorescent probe with enormous potential for SMT.
Here we used VHH15-CF640R to label individual 5-HT3Rs in the plasma membrane of living
cells. VHH15 binds to the 5-HT3R with high speciﬁcity and high afﬁnity, at the interface
between two adjacent A subunits [96]. The fact that up to ﬁve VHH15 molecules may bind to
the receptor could be problematic for single-molecule imaging; however by using picomolar
concentrations of VHH15 in order to label only a few tens of receptors per cell, one can
reasonably assume that only mono-labeled receptors will be observed. The choice of the
ﬂuorophore is of critical importance for SMT [272]. To fully beneﬁt from the reduced size of
the nanobody, the ﬂuorophore has to be small. In this respect, organic ﬂuorescent dyes are
the best candidates. Zanetti-Domingues et al. have recently evaluated what was the best dye
for SMT experiments [253] by analyzing the brightness, photostability and non-speciﬁcity
adhesion of many different dyes at the single-molecule level. Of the dyes they have examined,
CF640R appeared to be the dye of choice for excitation with red light.
VHH15-CF640R enabled us to monitor the lateral diffusion of individual native receptors
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with high precision over extended periods of time. Single-molecule trajectories of almost one
minute were recorded with 100 ms temporal resolution. Such long trajectories are usually
obtained using quantum dots or gold nanoparticles. Our SMT measurement allowed to high-
light an intriguing behavior of some 5-HT3Rs characterized by high diffusion coefﬁcients and
diffusing in a “pseudo-directed manner” in elongated domains with frequent back-and-forth
movements. It is tempting to interpret this particular diffusional behavior as the result of a
mechanism that would regulate the location of the 5-HT3R on nerve terminals [273]. However,
further experiments should be conducted in primary neurons to conﬁrm this hypothesis.
Previous investigations on the localization of the 5-HT3R in cell plasma membranes using
ﬂuorescence microscopy revealed a strong propensity of the receptor to colocalize with F-actin
[274, 275]. Disrupting the actin cytoskeleton with the actin depolymerizing drug latrunculin
A resulted in a signiﬁcant decrease of the receptor mobility, consistent with a diminution of
the fraction of receptors diffusing in elongated domains. This result contrast with previous
studies on other ionotropic receptors, in which treatment with latrunculin A led generally to a
reduction of the conﬁnement and increase of the diffusion coefﬁcient [276, 277, 278]. Emerit
et al. have shown that treatment of NG108-15 cells with latrucunlin A induced aggregation
of 5-HT3R clusters with residual F-actin [274]. This aggregation phenomenon is very likely
responsible for the observed decrease in receptor mobility. In addition to the actin meshwork,
microtubules seem also to play a role in the in the dynamic organization of the 5-HT3R in the
cell membrane, albeit to a far lesser extent.
4.6 Conclusion
In conclusion, VHH15-CF640R turned out to be an exceptional ﬂuorescent probe to image
single 5-HT3Rs in the plasma membrane of living cells. It allowed us to follow the diffusion of
endogenous receptors over long time regimes, thus revealing rare trajectories of some individ-
uals performing back-and-forth movements in elongated domains of several micrometers in
length. Our data suggest that actin ﬁlaments are involved in this peculiar diffusional behavior.
Future experiments will aim to ﬁgure out the dynamics of the 5-HT3R in the context of synaptic
biology.
Herein we have demonstrated the potential of ﬂuorescent nanobodies for direct labeling and
tracking of membrane receptors endogenously expressed in cultured neuronal cells. Because
of their small size, ﬂuorescent nanobodies may be of great interest to track the diffusion
of individual molecules in narrow and sterically hindered spaces such as the synaptic cleft.
Furthermore, as nanobodies can pass the blood-brain barrier [279], they could be used for
observing the properties of individual receptors directly in the brain of living animals.
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No one has ever seen or handled a single molecule. Molecular science, therefore, is one of those
branches of study which deal with things invisible and imperceptible by our senses, and which
cannot be subjected to direct experiment — James Clerk-Maxwell, Nature (1873).
What was once a scientist’s dream has become a reality. The 2014 Nobel Prize in Chemistry
was awarded to Eric Betzig, Stefan W. Hell, and William E. Moerner “for the development of
superresolved ﬂuorescence microscopy”. The ﬁrst great breakthrough that led to this Nobel
Prize was achieved in 1989, when Moerner demonstrated the possibility to optically detect a
single molecule in a crystal at cryogenic temperatures [148]. Previously, single molecules were
though to be optically undetectable [280]. This thesis aimed to exploit the recent advances in
experimental instrumentation that have made the detection of single molecules possible in
order to increase our understating of fundamental biological processes. In particular, we used
single-molecule ﬂuorescence tracking microscopy to investigate the diffusional behavior of
individual receptors embedded in the plasma membrane of living cells. Tracking of membrane
proteins is a unique way to gain insights not only into the dynamics and biological functions
of the tracked molecules, but also into the organization of the surrounding plasma membrane
and the molecular interactions taking place in this highly heterogenous environment.
Observing single molecules in living cells is not a trivial task. The speciﬁc labeling of a small
number of molecules of interest with a bright and photostable ﬂuorescent probe is a critical
prerequisite for a successful single-molecule tracking experiment. Thanks to the ultra-high
afﬁnity of the streptavidin-biotin couple and to the exceptional optical properties of QDots, we
were able follow the diffusion of individual NK1 receptors with both high spatial and temporal
resolution over long time periods. Thousands of single-molecule trajectories were recorded,
revealing a pronounced heterogeneity in the mobility of this prototypical GPCR. In order to
take into consideration potential changes in diffusion modes and to increase the amount of in-
formation that can be extracted from a single trajectory, we applied a segmentation algorithm,
which sequentially cuts the original trajectory into shorter sub-trajectories. Each segment was
then analyzed as an independent trajectory. For visualizing the huge amount of diffusional
data thus generated, we used two-dimensional density plots of the initial diffusion coefﬁ-
cients versus the Hurst parameter which is associated to the mode of motion of the receptor.
This novel way to represent single-molecule mobility, that we called “mobility pattern”, has
proven to be an excellent tool to resolve highly heterogenous receptor populations, follow their
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evolution over time and compare results obtained under different experimental conditions.
Our results revealed the central importance of clathrin in regulation of NK1R mobility. We
showed that the fraction of conﬁned receptors at the basal state depends on the quantity of
membrane-associated clathrin and that receptor conﬁnement is correlated to a decrease of
the canonical pathway activity of the receptor. These ﬁndings suggest the existence of a new
clathrin-based mechanism for regulation of NK1 receptor activity and further support the
critical role of membrane organization for regulation of GPCR signaling.
A major drawback of the widely used streptavidin-biotin couple is the risk of cross-linking (i.e.
one QDot binds several receptors), which could affect the diffusion and biological functions
of the target protein. Therefore we have generated a monovalent StrepTactin which can bind
to biotinylated but also to Strep-tagged receptors with high afﬁnity and virtually no risk of
cross-linking. Fluorescent derivatives were used for direct one-step labeling of Strep-tagged
receptors, bypassing the requirement of an initial biotinylation step. Single-particle tracking
of biotinylated NK1Rs using monovalent StrepTactin-conjugated QDots yielded very similar
diffusion coefﬁcients to those obtained with streptavidin QDots. This allowed us to exclude
cross-linking artifacts in the measured NK1R mobility.
Single domain antigen-binding fragments known as “nanobodies” have recently emerged as a
powerful alternative to traditional antibodies, and might be the new magic bullet of medicine
[281, 257]. In structural biology, nanobodies have been successfully used as crystallization
chaperones to decipher the structure of challenging targets such as membrane proteins [282].
Here we used a ﬂuorescent nanobody (VHH15-CF640R) to track endogenous 5-HT3 receptors
in neuronal cells. To our knowledge this is the ﬁrst time that a ﬂuorescent nanobody is used
to perform single-molecule tracking on a native membrane receptor. The long trajectories
recorded using VHH15-CF640R uncovered an extraordinary diversity of diffusional behav-
iors. In particular, receptors exhibiting back-and-forth movements in elongated domains of
several micrometers in length have been observed, underlying a hypothetical mechanism
for the regulation of 5-HT3 receptor on nerve terminals. The small size and monovalency of
nanobodies will be of great beneﬁt for future studies in narrow or sterically hindered spaces
such as the synaptic cleft. Furthermore, as nanobodies can pass the blood-brain barrier [279],
they could be used for observing the properties of individual receptors directly in the brain of
living animals. To sum up, we are convince that the potential of nanobody-based probes for
biophysical and biomedical research is huge and that ﬂuorescent nanobodies such as the one
presented in this thesis will allow to elucidate number of unknown cellular mechanisms in a
near future.
Our recent ability to observe and manipulate single molecules in living cells has revolutionized
our understanding of numerous biological processes. However, Maxwell is there to remind us
that science is constantly evolving and our knowledge is transient and never complete.
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A Single-molecule microscopy setups (Wide-ﬁeld/TIRF)
In this thesis, a homebuilt wide-ﬁeld ﬂuorescence microscopy setup with single-molecule
sensitivity was used (Figure A.1) [153]. During the thesis, the system has been upgraded to
perform total internal reﬂection ﬂuorescence (TIRF) imaging (Figure A.2).
Figure A.1: Wide-ﬁeld ﬂuorescence microscopy setup for single-molecule imaging. The
setup is composed of three distinct parts: a laser based excitation system, a microscope, and
a detection system. Each laser beam passes a half-wave plate and two mirrors, with one of
them being eventually a dichroic (DM1-3). The acousto-optic tunable ﬁlter (AOTF) controls
and modulates the laser power transmitted from each laser. The telescopic lens pair (L1-2)
expands the illumination beam to overﬁll the back aperture of the microscope objective via a
wide-ﬁeld lens (L3) and an dichroic mirror (DM4). The beam is collimated by the objective
and illuminates a wide region (wide-ﬁeld) of the sample. The emitted ﬂuorescence is collected
thought the same objective, ﬁltered using appropriate ﬁlters, and directed either towards
an electron multiplying charge coupled device (EMCCD) or a complementary metal-oxide-
semiconductor (CMOS) camera.
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Figure A.2: TIRF microscopy setup for single-molecule imaging.
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